Kwong A, Cheng DKL, Hsue CC, Hui SK, Leung RCY, Leung KC, Ngan KCR, Soong SI. BRCA mutation testing for ovarian cancer in the context of available targeted therapy: Survey and consensus of Hong Kong specialists. Asia-Pacific Journal of Clinical Oncology, 2019; 10.1111/ajco.13116

Chen H, Ji MF, Zong JF, Ko JMY, Dai W, Lung ML. Conventional and novel diagnostic biomarkers and approaches for detection of nasopharyngeal carcinoma. In Lee, WMA, Lung, ML and Ng, WT (Eds.), Nasopharyngeal Carcinoma: from Etiology to Clinical Practice. Academic Press, 2019.

Lam KO, Tong CC, Lee VHF, Luk MY, Lam CW. DPYD genotype-guided dose individualisation of fluoropyrimidine therapy: who and how? The Lancet Oncology, 2019, v. 20, p. e66; 10.1016/S1470-2045(18)30867-2

Tang H, Jiang L, Zhu C, Liu WMR, Wu Y, Yan Q, Liu M, Jia Y, Chen J, Qin Y, Lee VHF, Luo S, Wang Q, Guan X. Loss of cell adhesion molecule L1 like promotes tumor growth and metastasis in esophageal squamous cell carcinoma. Oncogene, 2019, Epub of 2019; 10.1038/s41388-018-0648-7

Lee WMA, Lung ML, Ng WT. Nasopharyngeal Carcinoma: from Etiology to Clinical Practice. Lee, WMA, Lung, ML & Ng, WT (Eds.). Cambridge, UK: Academic Press . 2019.

Lung ML, Dai W, Ko JMY. NPC Genetics and Genomics. In Lee, WMA, Lung, ML and Ng, WT (Eds.), Nasopharyngeal Carcinoma: from Etiology to Clinical Practice. Academic Press, 2019.

Yang X, Liang R, Liu C, Liu AJ, Cheung MPL, Liu X, Man OY, Guan X, Lung HL, Cheung MCH. SOX9 is a dose-dependent metastatic fate determinant in melanoma. Journal of Experimental and Clinical Cancer Research, 2019, v. 38 n. 1, article no. 17, p. 1-19; 10.1186/s13046-018-0998-6

Lee VHF, Kwong DLW, Leung TW, Choi CW, O'Sullivan B, Lam KO, Lai V, Khong PL, Chan SK, Ng CY, Tong CC, Ho PYP, Chan WLW, Wong LS, Leung DKC, Chan SY, So TH, Luk MY, Lee WMA. The addition of pretreatment plasma Epstein-Barr virus DNA into the eighth edition of nasopharyngeal cancer TNM stage classification. International Journal of Cancer, 2019, v. 144 n. 7, p. 1713-1722; 10.1002/ijc.31856

Yan HHN, Siu HC, Law SYK, Ho RSL, Yue SKS, Tsui WY, Chan D, Chan AS, Ma SKY, Lam KO, Bartfeld S, Man HY, Lee CH, Chan ASY, Wong WHJ, Cheng SWP, Chan KW, Zhang J, Shi J, Fan X, Kwong DLW, Mak TW, Yuen ST, Clevers H, Leung SY. A Comprehensive Human Gastric Cancer Organoid Biobank Captures Tumor Subtype Heterogeneity and Enables Therapeutic Screening. Cell Stem Cell, 2018, v. 23 n. 6, p. 882-897.e11; 10.1016/j.stem.2018.09.016

Tong CC, Lam CW, Lam KO, Lee VHF, Luk MY. A Novel DPYD Variant Associated With Severe Toxicity of Fluoropyrimidines: Role of Pre-emptive DPYD Genotype Screening. Frontiers in Oncology, 2018, v. 8, p. 279; 10.3389/fonc.2018.00279

Chen LL, Zou B, Lee VHF, Yan H. Analysis of the Relative Movements Between EGFR and Drug Inhibitors Based on Molecular Dynamics Simulation. Current Bioinformatics, 2018, v. 13 n. 3, p. 299-309; 10.2174/1574893612666171006155855

Shi D, Chen YH, Lam TC, Leonard D, Balboni TA, Schoenfeld A, Skamene S, Cagney D, Chi J, Cho C, Harris M, Ferrone ML, Hertan LM. Assessing the utility of a prognostication model to predict 1-year mortality in patients undergoing radiation therapy for spinal metastases. The Spine Journal, 2018, v. 18, p. 935-940; 10.1016/j.spinee.2017.10.005

Shi DD, Hertan LM, Lam TC, Skamene S, Chi JH, Groff M, Cho CH, Ferrone ML, Harris M, Chen YH, Balboni TA. Assessing the utility of the spinal instability neoplastic score (SINS) to predict fracture after conventional radiation therapy (RT) for spinal metastases.. Practical Radiation Oncology, 2018, v. 8 n. 5, p. e285-e294; 10.1016/j.prro.2018.02.001

Hui TH, Tang YH, Yan Z, Yip TC, Fong HW, Cho WC, Ngan KC, Shum HC, Lin Y. Cadherin- and Rigidity-Dependent Growth of Lung Cancer Cells in a Partially Confined Microenvironment. ACS Biomaterials Science and Engineering, 2018, v. 4, n. 2, p. 446-455; 10.1021/acsbiomaterials.7b00130

Cheung KM, Ngan KCR, Chow JCH, Lee TY, Li KWS, Cheng HC, Leung CWL, Yiu HHY, Yau S, Au JSK, Wong KH. Can Neoadjuvant Chemotherapy before Definitive Surgery Improve Outcome in Operable Stage IVA Oral Cavity Cancers? Hong Kong Journal of Radiology, 2018, v. 21, p. 124-131; 10.12809/hkjr1816962

Liu X, Zhang Y, Tang LL, Le QT, Chua MLK, Wee JTS, Lee NY, O'Sullivan B, Lee WMA, Sun Y, Ma J. Characteristics of Radiotherapy Trials Compared With Other Oncological Clinical Trials in the Past 10 Years. JAMA Oncology, 2018, v. 4, p. 1073; 10.1001/jamaoncol.2018.0887

Ng HY, Li J, Tao L, Lam AK, Chan KW, Ko JMY, Yu Z, Wong M, Li B, Lung ML. Chemotherapeutic Treatments Increase PD-L1 Expression in Esophageal Squamous Cell Carcinoma through EGFR/ERK Activation. Translational Oncology, 2018, v. 11, p. 1323-1333; 10.1016/j.tranon.2018.08.005

Lam KO, Kwong DLW. Chemotherapy for Esophageal Adenocarcinoma. In Lam, AK (Eds.), Esophageal Adenocarcinoma: Methods and Protocols, p. 19-34. New York, N.Y.: Humana Press, 2018; 10.1007/978-1-4939-7734-5_3

Wu YL, Lee VHF, Liam CK, Lu S, Park K, Srimuninnimit V, Wang J, Zhou CC, Appius A, Button P, Hooper G, Palma JF, Schulze K, Scudder S, Shames DS, Yin AY, Zhang GL, Mok T. Clinical utility of a blood-based EGFR mutation test in patients receiving first-line erlotinib therapy in the ENSURE, FASTACT-2, and ASPIRATION studies. Lung Cancer, 2018, v. 126, p. 1-8; 10.1016/j.lungcan.2018.10.004

Ho CHM, Chiang CL, Lee FAS, Choi CW, Chan JCH, Yeung CSY, Huang JJ, Chan MKH, Blanck O, Wong FCS. Comparison of platelet-albumin-bilirubin (PALBI), albumin-bilirubin (ALBI), and child-Pugh (CP) score for predicting of survival in advanced hcc patients receiving radiotherapy (RT). Oncotarget, 2018, v. 9, p. 28818-28829; 10.18632/oncotarget.25522

Ng WT, Tung SY, Lee VHF, Ngan KCR, Choi CW, Chan LLK, Leung TW, Siu LL, Lu TX, Tan T, Tan EH, Sze CKH, Ng AWY, Yiu HHY, O'Sullivan B, Chappell R, Lee WMA. Concurrent-Adjuvant Chemoradiation Therapy for Stage III-IVB Nasopharyngeal Carcinoma: Exploration for Achieving Optimal 10-Year Therapeutic Ratio. International Journal of Radiation Oncology - Biology - Physics, 2018, v. 101 n. 5, p. 1078-1086; 10.1016/j.ijrobp.2018.04.069

Chen X, Zhang J, Luo JH, Wu S, Yuan G, Ma NF, Feng Y, Cai M, Chen R, Lu J, Jiang L, Chen JW, Jin XH, Liu H, Chen W, Guan X, Kang T, Zhou FJ, Xie D. CSTF2-induced shortening of the RAC1 3'UTR promotes the pathogenesis of urothelial carcinoma of the bladder. Cancer Research, 2018, v. 78 n. 20, p. 5848-5862; 10.1158/0008-5472.can-18-0822

Gregoire V, Evans M, Le QT, Bourhis J, Budach V, Chen A, Eisbruch A, Feng M, Giralt J, Gupta T, Hamoir M, Helito JK, Hu C, Hunter K, Johansen J, Kaanders J, Laskar SG, Lee WMA, Maingon P, Makitie A, Micciche' F, Nicolai P, O'Sullivan B, Poitevin A, Porceddu S, Skladowski K, Tribius S, Waldron J, Wee J, Yao M, Yom M, Zimmermann F, Crau C. Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG consensus guidelines. Radiotherapy & Oncology, 2018, v. 126 n. 1, p. 3-24; 10.1016/j.radonc.2017.10.016

Zhou Y, Wang L, Ban X, Zeng T, Zhu Y, Li M, Guan X, Li Y. DHRS2 inhibits cell growth and motility in esophageal squamous cell carcinoma. Oncogene, 2018, v. 37, p. 1086-1094; 10.1038/onc.2017.383

Wang L, Li M, Zhan Y, Ban X, Zeng T, Zhu Y, Yun J, Guan X, Li Y. Down-regulation of POTEG predicts poor prognosis in esophageal squamous cell carcinoma patients. Molecular Carcinogenesis, 2018, v. 57, p. 886-895; 10.1002/mc.22809

Sin ST, Li Y, Liu M, Yuan YF, Ma SKY, Guan X. Down-regulation of TROP-2 Predicts Poor Prognosis of Hepatocellular Carcinoma Patients. Hepatology Communications, 2018, v. 2 n. 11, p. 1408-1414. ; 10.1002/hep4.1242

Kessel KA, Lee WMA, Bentzen SM, Vikram B, Nüsslin F, Combs SE. Editorial: Data Based Radiation Oncology: Design of Clinical Trials. Frontiers in Oncology, 2018, v. 8, p. 34:1-34:1. ; 10.3389/fonc.2018.00034

Yeo W, Luk MY, Soong IS, Yuen TYS, Ng TY, Mo FKF, Chan K, Wong SY, Tsang J, Leung C, Suen JJS, Ngan RKC. Efficacy and tolerability of trastuzumab emtansine in advanced human epidermal growth factor receptor 2-positive breast cancer. Hong Kong Medical Journal, 2018, v. 24, n. 1, p. 56-62; 10.12809/hkmj176808

Chai WY, Cheung AKL, Dai W, Ko JMY, Lee NPY, Chan KT, Law SYK, Lung ML. Elevated levels of serum nidogen-2 in esophageal squamous cell carcinoma. Cancer Biomarkers, 2018, v. 21, p. 583-590; 10.3233/CBM-170484

Lin W, Yip YL, Jia LJ, Deng W, Zheng H, Dai W, Ko JMY, Lo KW, Chung GTY, Yip KY, Lee SD, Kwan JSH, Zhang J, Liu TF, Chan YW, Kwong DLW, Lee VHF, Nicholls JM, Busson P, Liu XF, Chiang AKS, Hui KF, Kwok H, Cheung ST, Cheung YC, Chan CK, Li B, Cheung A, Hau PM, Zhou Y, Tsang CM, Middeldorp J, Chen H, Lung ML, Tsao GSW. Establishment and characterization of new tumor xenografts and cancer cell lines from EBV-positive nasopharyngeal carcinoma. Nature Communications, 2018, v. 9, p. 4663; 10.1038/s41467-018-06889-5

Yip YL, Lin W, Deng W, Jia LJ, Lo KW, Busson P, Verillaud B, Liu X, Tsang CM, Lung ML, Tsao GSW. Establishment of a nasopharyngeal carcinoma cell line capable of undergoing lytic Epstein-Barr virus reactivation. Laboratory Investigation, 2018; 10.1038/s41374-018-0034-7

Bai H, Liao Y, Cai M, Ma N, Zhang Q, Chen J, Zhang J, Wang F, Wang C, Chen W, Jin X, Xu R, Guan X, Xie D. Eukaryotic Initiation Factor 5A2 Contributes to the Maintenance of CD133(+) Hepatocellular Carcinoma Cells via the c-Myc/microRNA-29b Axis. Stem Cells, 2018, v. 36 n. 2, p. 180-191. ; 10.1002/stem.2734

Jiang C, Chen J, Xie S, Zhang L, Xiang Y, Lung ML, Kam NW, Kwong DLW, Cao S, Guan X. Evaluation of circulating EBV microRNA BART2-5p in facilitating early detection and screening of nasopharyngeal carcinoma. International Journal of Cancer, 2018; 10.1002/ijc.31642

Li L, Li J, Yang H, Zhang X, Liu L, Li Y, Zeng T, Zhu YH, Li XD, Li Y, Xie D, Fu L, Guan X. Expansion of cancer stem cell pool initiates lung cancer recurrence before angiogenesis. Proceedings of the National Academy of Sciences, 2018, v. 115 n. 38, p. E8948-E8957; 10.1073/pnas.1806219115

Yang LI, Lam KO, Lee VHF, Lee WMA. Gefitinib-induced toxic epidermal necrolysis in a patient with metastatic non-small cell lung cancer. Hong Kong Journal of Radiology, 2018, v. 21 n. 2, p. e8-e11; 10.12809/hkjr1816416

Ng WT, Wong ECY, Lee VHF, Chan YW, Lee WMA. Head and neck cancer in Hong Kong. Japanese Journal of Clinical Oncology, 2018, v. 48 n. 1, p. 13-21; 10.1093/jjco/hyx151

Li L, Liu YD, Zhan YT, Zhu YH, Li Y, Xie D, Guan X. High levels of CCL2 or CCL4 in the tumor microenvironment predict unfavorable survival in lung adenocarcinoma. Thoracic Cancer, 2018, v. 9 n. 7, p. 775-784; 10.1111/1759-7714.12643

Cheung TT, Kwok PC, Chan S, Cheung CC, Lee AS, Lee VHF, Cheng HC, Chia NH, Chong CCN, Lai TW, Law ALY, Luk MY, Tong CC, Yau TCC. Hong Kong Consensus Statements for the Management of Unresectable Hepatocellular Carcinoma. Liver Cancer, 2018, v. 7, p. 40-54; 10.1159/000485984

Li L, Yang H, Li Y, Li XD, Zeng T, Lin S, Zhu Y, Guan X. Hypoxia restrains the expression of complement component 9 in tumor-associated macrophages promoting non-small cell lung cancer progression. Cell Death Discovery, 2018, v. 4, p. 63:1-63:12; 10.1038/s41420-018-0064-3

Zhang N, Fielding R, Soong SI, Chan KKK, Lee CCY, Ng A, Sze WK, Tsang WHJ, Lee VHF, Lam WWT. Illness perceptions as predictors of psychological distress among head and neck cancer survivors: a longitudinal study. Head & Neck, 2018, v. 40, p. 2362-2371; 10.1002/hed.25343

Lee WMA, Ng WT, Pan JJ, Poh SS, Ahn YC, AlHussain H, Corry J, Grau C, Gregoire V, Harrington KJ, Hu CS, Kwong DLW, Langendijk JA, Le QT, Lee NY, Lin JC, Lu TX, Mendenhall WM, O'Sullivan B, Ozyar E, Peters LJ, Rosenthal DI, Soong YL, Tao YG, Yom SS, Wee JT. International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma. Radiotherapy & Oncology, 2018, v. 126 n. 1, p. 25-36; 10.1016/j.radonc.2017.10.032

Ko JMY, Tsang HK, Dai W, Choi SSA, Leong ML, Ngan KCR, Kwong DLW, Cheng A, Lee WMA, Ng WT, Tung S, Lee VHF, Lam KO, Chan KC, Lung ML. Leukocyte telomere length associates with nasopharyngeal carcinoma risk and survival in Hong Kong Chinese. International Journal of Cancer, 2018; 10.1002/ijc.31617

Chiu WHK, Lam KO, An H, Cheung TC, Lau KS, Choy TS, Lee VHF. Long-term outcomes and recurrence pattern of 18F-FDG PET-CT complete metabolic response in the first-line treatment of metastatic colorectal cancer: a lesion-based and patient-based analysis. BMC Cancer, 2018, v. 18, p. 776; 10.1186/s12885-018-4687-9

Kwong DLW, Tsang RKY. Nasopharyngeal Carcinoma. In Watkinson, J and Clarke, R (Eds.), Scott-Brown-™s Otorhinolaryngology and Head and Neck Surgery (8th ed.). London, UK: CRC Press, 2018.

Lee VHF, Chan SY, Tong CC, Lam KO, Kwong DLW, Leung TW, Lee WMA. New hope for advanced nasopharyngeal cancer- an Epstein-Barr virus-driven endemic malignancy? Translational Cancer Research, 2018, v. 7, p. S53-S57; 10.21037/tcr.2017.12.25

Lee SF, Chiang CL, Lee FAS, Wong YW, Poon CMM, Wong CSF, Tung SY. Outcome of neoadjuvant chemoradiation in MRI staged locally advanced rectal cancer: Retrospective analysis of 123 Chinese patients. Journal of the Formosan Medical Association, 2018, v. 117 n. 9, p. 825-832; 10.1016/j.jfma.2017.10.002

Dai Y, Liu L, Zeng T, Liang J, Song Y, Chen K, Li Y, Chen L, Zhu Y, LI J, Li Y, Xie D, Yuan Y, Guan X. Overexpression of MUC13, a poor prognostic predictor, promotes cell growth by activating Wnt signaling in hepatocellular carcinoma. The American Journal of Pathology, 2018, v. 188, p. 378-391; 10.1016/j.ajpath.2017.10.016

Lee VHF, Yu E, Claude K. Palliative Care for Chest Tumors - Hong Kong, France and Canada. Current Cancer Therapy Reviews, 2018, v. 14, p. 167-180; 10.2174/1573394714666180208143101

Li Y, Lin S, Li L, Tang Z, Hu Y, Ban X, Zeng T, Zhou Y, Zhu YH, Gao S, Deng W, Zhang X, Xie D, Yuan Y, Huang P, Li J, Cai Z, Guan X. PDSS2 deficiency induces hepatocarcinogenesis by decreasing mitochondrial respiration and reprogramming glucose metabolism. Cancer Research, 2018, v. 78 n. 16, p. 4471-4481; 10.1158/0008-5472.CAN-17-2172

Zou B, Lee VHF, Yan H. Prediction of sensitivity to gefitinib/erlotinib for EGFR mutations in NSCLC based on structural interaction fingerprints and multilinear principal component analysis. BMC Bioinformatics, 2018, v. 19 n. 1, p. 88; 10.1186/s12859-018-2093-6

Kwan KYH, Lam TC, Choi CW, Koh HY, Cheung KMC. Prediction of survival in patients with symptomatic spinal metastases: Comparison between the Tokuhashi score and expert oncologists. Surgical Oncology, 2018, v. 27, p. 7-10; 10.1016/j.suronc.2017.11.001

Chan LH, Zhou L, Ng KY, Wong TL, Lee TK, Sharma R, Loong HC, Ching YP, Yuan YF, Xie D, Lo CM, Man K, Artegiani B, Clevers H, Yan HHN, Leung SY, Richard S, Guan X, Huen MSY, Ma SKY. PRMT6 Regulates RAS/RAF Binding and MEK/ERK-Mediated Cancer Stemness Activities in Hepatocellular Carcinoma through CRAF Methylation. Cell Reports, 2018, v. 25 n. 3, p. 690-701.e8; 10.1016/j.celrep.2018.09.053

Ng WT, Ngan KC, Kwong DLW, Tung SY, Yuen KT, Kam MKM, Sze CKH, Yiu HHY, Chan LLK, Lung ML, Lee WMA. Prospective, Multicenter, Phase 2 Trial of Induction Chemotherapy Followed by Bio-Chemoradiotherapy for Locally Advanced Recurrent Nasopharyngeal Carcinoma. International Journal of Radiation Oncology*Biology*Physics, 2018, v. 100, p. 630-638; 10.1016/j.ijrobp.2017.11.038

Fernandez-Alvarez V, Lopez F, Suarez C, Strojan P, Eisbruch A, Silver CE, Mendenhall WM, Langendijk JA, Rinaldo A, Lee WMA, Beitler JJ, Smee R, Alvarez J, Ferlito A. Radiation-induced carotid artery lesions. Strahlentherapie und Onkologie: Zeitschrift fuer Radiologie, Strahlenbiologie, Strahlenphysik, 2018, v. 194 n. 8, p. 699-710; 10.1007/s00066-018-1304-4

Kwong DLW, Lam KO. Radiotherapy for Esophageal Adenocarcinoma. In Lam, AK (Eds.), Esophageal Adenocarcinoma: Methods and Protocols, p. 7-17. New York, N.Y.: Humana Press, 2018; 10.1007/978-1-4939-7734-5_2

Lam TH, Wong KH, Chan KKL, Chan MCM, Chao DVK, Cheung ANY, Fan CYM, Ho J, Hui EP, Law KO, Law CK, Law WL, Loong HHF, Ngan KCR, Tsang THF, Wong MCS, Yeung RMW, Ying ACH, Ching R. Recommendations on prevention and screening for breast cancer in Hong Kong. Hong Kong Medical Journal, 2018, v. 24 n. 3, p. 298-306; 10.12809/hkmj177037

Lam TH, Wong KH, Chan KKL, Chan MCM, Chan DVK, Cheung ANY, Fan CYM, Ho D, Hui EP, Lam KO, Law CK, Law WL, Loong HHF, Ngan RKC, Tsang THF, Wong MCS, Yeung RMW, Ying ACH. Recommendations on prevention and screening for colorectal cancer in Hong Kong. Hong Kong Medical Journal, 2018, v. 24 n. 5, p. 521-526; 10.12809/hkmj177095

Ming X, Zhang X, Cao T, Zhang L, Qi J, Kam NW, Tang X, Cui Y, Zhang B, Li Y, Qin Y, Guan X. RHCG suppresses tumorigenicity and metastasis in esophageal squamous cell carcinoma via inhibiting NF-kB signaling and MMP1 expression. Theranostics, 2018, v. 8 n. 1, p. 185-198; 10.7150/thno.21383

Chow JCH, Au KH, Mange OWK, Cheung KM, Ngan KCR. Risk, pattern and survival impact of second primary tumors in patients with nasopharyngeal carcinoma following definitive intensity-modulated radiotherapy. Asia-Pacific Journal of Clinical Oncology, 2018; 10.1111/ajco.12994

Lau HP, Chow AYM, Wong FKD, Chan JSM, Chan CHY, Ho RTH, So TH, Lam TC, Lee VHF, Lee WMA. Study Protocol of a Randomized Controlled Trial Comparing Integrative Body-Mind-Spirit Intervention and Cognitive Behavioural Therapy in Fostering Quality of Life of Patients with Lung Cancer and their Family Caregivers. Journal of Evidence-Based Social Work: advances in practice, programming, research, and policy, 2018, v. 15 n. 3, p. 258-276; 10.1080/23761407.2018.1435325

Lee VHF, Kwong DLW. Systemic Treatment of Chest Tumors: Highlighting Some Differences Between Eastern and Western Countries. Current Cancer Therapy Reviews, 2018, v. 14, p. 120-136; 10.2174/1573394714666180208143821

Lam KO, Kwong DLW. Target Therapy for Esophageal Adenocarcinoma. In Lam, AK (Eds.), Esophageal Adenocarcinoma: Methods and Protocols, p. 51-65. New York, N.Y.: Humana Press, 2018; 10.1007/978-1-4939-7734-5_5

Mai Z, Lin J, Chiang SC, Ngan KCR, Kwong DLW, Ng WT, Ng AWY, Yuen KT, Ip DKM, Chan YH, Lee WMA, Ho DSY, Lung ML, Lam TH. Test-retest reliability of a computer-assisted self-administered questionnaire on early life exposure in a nasopharyngeal carcinoma case-control study. Scientific Reports, 2018, v. 8, p. 7052:1-7052:7; 10.1038/s41598-018-25046-y

Lam PL, Lam TC, Choi CW, Lee WMA, Yuen KK, Leung TW. The impact of palliative care training for oncologists and integrative palliative service in a public-funded hospital cluster: a retrospective cohort study. Supportive Care in Cancer, 2018, v. 26 n. 5, p. 1393-1399; 10.1007/s00520-017-3963-6

Zhong Q, Liu Z, Lin Z, Hu Z, Yuan L, Liu Y, Zhou A, Xu L, Hu L, Wang Z, Guan X, Hao J, Lui V, Guo L, Mai H, Chen M, Han F, Xie Y, Grandis J, Zhang X. The RARS-MAD1L1 fusion gene Induces cancer stem cell-like properties and therapeutic resistance in nasopharyngeal carcinoma. Clinic Cancer Research, 2018, v. 24, p. 659-673; 10.1158/1078-0432.CCR-17-0352

Au KH, Ngan RKC, Ng AWY, Poon DMC, Ng WT, Yuen KT, Lee VHF, Tung SY, Chan ATC, Sze HCK, Cheng ACK, Lee AWM, Kwong DLW, Tam AHP. Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: A report of 3328 patients (HKNPCSG 1301 study). Oral Oncology, 2018, v. 77, p. 16-21; 10.1016/j.oraloncology.2017.12.004

Zhang B, Zhang Z, Li L, Qin Y, Liu H, JIANG C, Zeng T, Li M, Xie D, Li Y, Guan X, Zhu Y. TSPAN15 interacts with BTRC to promote oesophageal squamous cell carcinoma metastasis via activating NF-kB signaling. Nature Communications, 2018, v. 9, p. 1423:1-1423:12; 10.1038/s41467-018-03716-9

Lee AWM, Tung SY, Ng WT, Lee V, Ngan RKC, Choi HCW, Chan LLK, Siu SL, Ng AWY, Leung TW, Yiu HHY, O'Sullivan B, Chappell R. A multicenter, phase 3, randomized trial of concurrent chemoradiotherapy plus adjuvant chemotherapy versus radiotherapy alone in patients with regionally advanced nasopharyngeal carcinoma: 10-year outcomes for efficacy and toxicity. Cancer, 2017, v. 123, n. 21, p. 4147-4157; 10.1002/cncr.30850

Li JS, Xu ZY, Chen ZJ, Xu XP, Jing HM, Zhou L, Chen X, Lam KO, Lee WMA. A New Model of Clinical Pathway for Comprehensive Management of Nasopharyngeal Carcinoma: Research and Clinical Practice. 2017, v. 26 n. 2, p. 106-110.

Wu VWC, Ying MTC, Kwong DLW. A study on the post-radiotherapy changes of temporomandibular joint in nasopharyngeal carcinoma patients. British Journal of Radiology, 2017, v. 90, p. 20170375; 10.1259/bjr.20170375

Ngan RKC. A tribute to radiologists (and the multidisciplinary team) in combating liver cancer. Hong Kong Journal of Radiology, 2017, v. 20, n. 3, p. 172-174; 10.12809/hkjr1716448

Yeo W, Lam KO, Law AL, Chiang CL, Lee CC, Au KH. Adjuvant S-1 chemotherapy after curative resection of gastric cancer. Hong Kong Medical Journal, 2017, v. 23 n. 3, p. 315-316; 10.12809/hkmj176283

Yeo W, Lam KO, Law LYA, Lee CCY, Chiang CL, Au KH, Mo KF, So TH, Lam KC, Ng WT, Li L. Adjuvant S-1 chemotherapy after curative resection of gastric cancer in Chinese patients: assessment of treatment tolerability and associated risk factors. Hong Kong Medical Journal, 2017, v. 23 n. 1, p. 54-62; 10.12809/hkmj164885

So TH, Lee VHF, Lam KO. Aflibercept-induced Nephrotic Syndrome. Hong Kong Journal of Radiology, 2017, v. 20, p. 146-148; 10.12809/hkjr1716809

Lam TC, Sahgal A, Lo S, Chang E. An update on radiation therapy for brain metastases. Chinese Clinical Oncology, 2017, v. 6, p. 35-35; 10.21037/cco.2017.06.02

Yan Q, Jiang L, Liu M, Yu D, Zhang Y, Li Y, Fang S, Li Y, Zhu Y, Yuan Y, Guan X. ANGPTL1 interacts with integrin α1β1 to suppress HCC angiogenesis and metastasis by inhibiting JAK2/STAT3 signaling. Cancer Research, 2017, v. 77, p. 5831-5845. ; 10.1158/0008-5472.CAN-17-0579

Tsang JS, Tong KHD, Lam KO, Law TT, Wong YHI, Chan KKD, Chan SY, Kwong DLW, Law SYK. Appropriate timing for surgery after neoadjuvant chemoradiation for esophageal cancer. Diseases of the Esophagus, 2017, v. 30 n. 9, p. 1-8; 10.1093/dote/dox062

Jiang L, Liu M, Li Y, Kwong DLW, Guan X. Calcium-binding protein 39 promotes hepatocellular carcinoma growth and metastasis by activating extracellular signal-regulated kinase signaling pathway. Hepatology, 2017, v. 66 n. 5, p. 1529-1545; 10.1002/hep.29312

Xu W, Li B, Guan X, Chung SK, Yang W, Yip YL, Law SYK, Chan KT, Lee NPY, Chan KW, Xu LY, Li EM, Tsao GSW, He QY, Cheung A. Cancer cell-secreted IGF2 instigates fibroblasts and bone marrow-derived vascular progenitor cells to promote cancer progression. Nature Communications, 2017, v. 8, p. 14399:1-17; 10.1038/ncomms14399

Yuan H, Ai QY, Kwong DLW, Fong DYT, King AD, Vardhanabhuti V, Lee VHF, Khong PL. Cervical nodal volume for prognostication and risk stratification of patients with nasopharyngeal carcinoma, and implications on the TNM-staging system. Scientific Reports, 2017, v. 7 n. 1, p. 10387; 10.1038/s41598-017-10423-w

Chiang CL. Combination of immunotherapy and radiotherapy. Hong Kong Medical Diary, 2017, v. 22 n. 6, p. 26-28.

Zeng ZC, Seong J, Yoon SM, Cheng JCH, Lam KO, Lee AS, Law LYA, Zhang JY, Hu Y. Consensus on Stereotactic Body Radiation Therapy for Small-Sized Hepatocellular Carcinoma at the 7th Asia-Pacific Primary Liver Cancer Expert Meeting. Liver Cancer, 2017, v. 6, p. 264-274; 10.1159/000475768

Zou B, Lee VHF, Chen LJ, Ma LC, Wang DD, Yan H. Deciphering mechanisms of acquired T790M mutation after EGFR inhibitors for NSCLC by computational simulations. Scientific Reports, 2017, v. 7, p. 6595:1-6595:13; 10.1038/s41598-017-06632-y

Wang F, Tse LA, Chan WC, Kwok CCH, Leung SL, Wu C, Mang OWK, Ngan RKC, Li M, Yu WC, Tsang KH, Law SH, Miao X, Wu C, Zheng Y, Wu F, Yang X, Yu ITS. Disparities of time trends and birth cohort effects on invasive breast cancer incidence in Shanghai and Hong Kong pre- and post-menopausal women. BMC Cancer, 2017, v. 17, n. 1; 10.1186/s12885-017-3359-5

Huang B, Kwong DLW, Lai V, Chan Q, Whitcher B, Khong PL. Dynamic Contrast-Enhanced Magnetic Resonance Imaging of Regional Nodal Metastasis in Nasopharyngeal Carcinoma: Correlation with Nodal Staging. Contrast Media & Molecular Imaging (CMMI), 2017, v. 2017, p. 1-6; 10.1155/2017/4519653

Zhang J, Jia LJ, Lin W, Yip YL, Lo KW, Lau VM-Y, Zhu D, Tsang CM, Zhou Y, Deng W, Lung HL, Lung ML, Cheung LM, Tsao GSW. Epstein-barr Virus-encoded Latent Membrane Protein 1 Upregulates Glucose Transporter 1 Transcription Via The Mtorc1/nf-kb Signaling Pathways. Journal of Virology, 2017, v. 91, p. e02168-16; 10.1128/JVI.02168-16

Cao T, Lin SH, Fu L, Tang Z, Che CM, Zhang L, Ming X, Liu TF, Tang XM, Tan BB, Xiang D, Li F, Chan OY, Xie D, Cai Z, Guan X. Eukaryotic translation initiation factor 5A2 promotes metabolic reprogramming in hepatocellular carcinoma cells. Carcinogenesis, 2017, v. 38 n. 1, p. 94-104; 10.1093/carcin/bgw119

Lee VHF, Chang ATY, Ng WT, Lee WMA. Evidenced-Based Management of Nasopharyngeal Cancers in the Modern Era. In Sullivan, D (Ed.), Chemoradiotherapy: Concurrent Uses, Efficacy and Impact on Prognosis, p. 1-34. Hauppauge, NY: Nova Science Publishers, 2017.

Lau CC, Ng KY, Wong TL, Tong M, Lee TK, Ming X, Law SYK, Lee NPY, Cheung A, Qin YR, Chan KW, Ning W, Guan X, Ma SKY. FSTL1 promotes metastasis and chemoresistance in esophageal squamous cell carcinoma through NFkB-BMP signaling cross-talk. Cancer Research, 2017, v. 77 n. 21, p. 5886; 10.1158/0008-5472.CAN-17-1411

Cao T, Xiang D, Liu B, Huang T, Tan B, Zeng C, Wang Z, Ming X, Zhang L, Jin G, Li F, Wu J, Guan X, Lu D, Fu L. FZD7 is a novel prognostic marker and promotes tumor metastasis via WNT and EMT signaling pathways in esophageal squamous cell carcinoma. Oncotarget, 2017, v. 8, p. 65957-65968; 10.18632/oncotarget.19586

Lui LCY, Wong KH, Ngan R, Siu SWK, Chow E, Lo SH, Yuen KK, Yau YSH, Wong KY, Yeung R. Hong Kong College of radiologists' palliative medicine training programme. Hong Kong Journal of Radiology, 2017, v. 20, n. 3, p. 227-231; 10.12809/hkjr1716802

Lee VHF, Kwong DLW, Leung TW, Ng CY, Lam KO, Tong CC, Sze CKH. Hyperfractionation compared to standard fractionation in intensity-modulated radiation therapy for patients with locally advanced recurrent nasopharyngeal carcinoma. European Archives of Oto-Rhino-Laryngology, 2017, v. 274, p. 1067-1078; 10.1007/s00405-016-4339-0

Li L, Zhu YH, Li Y, Guan X. Identification of chemokine CXCL10 in tumor microenvironment by antibody array as a prognostic marker in hepatocellular carcinoma. Neoplasma, 2017; 10.4149/neo_2017_517

Lee VHF, Ng SCY, Kwong DLW, Lam KO, Leung TW. Impact of intravenous contrast used in computed tomography on radiation dose to carotid arteries and thyroid in intensity-modulated radiation therapy planning for nasopharyngeal carcinoma.. Medical Dosimetry, 2017, v. 42, p. 137-144; 10.1016/j.meddos.2017.02.005

Chow R, Zhang L, Soong I S, Mang O WK, Lui L CY, Wong K H, Siu S WK, Lo S H, Yuen K K, Yau Y SH, Wong K Y, Leung C, Wong S Y, Ngan R, Chow E, Yeung R. Inter-rater reliability of examiners in the Hong Kong College of radiologists' palliative medicine oral examination. Hong Kong Journal of Radiology, 2017, v. 20, n. 3, p. 232-236; 10.12809/hkjr1716804

Lai V, Lee VHF, Lam KO, Huang B, Chan Q, Khong PL. Intravoxel incoherent motion MR imaging in nasopharyngeal carcinoma: Comparison and correlation with dynamic contrast enhanced MR imaging. Oncotarget, 2017, v. 8 n. 40, p. 68472-68482; 10.18632/oncotarget.19575

Peng F, Tang H, Liu P, Shen J, Guan X, Xie X, Gao J, Xiong L, Jia L, Chen J, Peng C. Isoliquiritigenin modulates miR-374a/PTEN/Akt axis to suppress breast cancer tumorigenesis and metastasis. Scientific Reports, 2017, v. 7 n. 1, p. 9022:1-14; 10.1038/s41598-017-08422-y

Chan JCH, Leung AKC, Fong ST, Chiu HM, Ngan RKC. Management of chordoma in a tertiary hospital in Hong Kong. Hong Kong Journal of Radiology, 2017, v. 20, n. 1, p. 28-33; 10.12809/hkjr1716854

Lee VHF, Kwong DLW, Lam KO, Lai YC, Li YM, Tong CC, Ho PYP, Chan WLW, Wong LS, Leung DKS, Chan SY, Chan FT, Leung TW, Lee WMA. Metronomic oral cyclosphosphamide as third-line systemic treatment or beyond in patients with inoperable locoregionally advanced recurrent or metastatic nasopharyngeal carcinoma. Medicine, 2017, v. 96 n. 15, article no. e6518, p. 1-9; 10.1097/MD.0000000000006518

Li B, Xu W, Han L, Chan KT, Tsao GSW, Lee NPY, Law SYK, Xu LY, Li EM, Chan KW, Qin YR, Guan X, He QY, Cheung A. MicroRNA-377 suppresses initiation and progression of esophageal cancer by inhibiting CD133 and VEGF. Oncogene, 2017, v. 36 n. 28, p. 3986-4000; 10.1038/onc.2017.29

Yue PY, Ha WY, Lau CC, Cheung FMF, Lee WMA, Ng WT, Ngan KCR, Yau CC, Kwong DLW, Lung HL, Mak NK, Lung ML, Wong RNS. MicroRNA profiling study reveals miR-150 in association with metastasis in nasopharyngeal carcinoma. Scientific Reports, 2017, v. 7, p. 12012:1-12012:11; 10.1038/s41598-017-10695-2

Li L, Zeng T, Zhang B, Li Y, Zhu Y, Guan X. Overexpression of HN1L promotes cell malignant proliferation in non-small cell lung cancer. Cancer Biology & Therapy, 2017, v. 18, p. 904-915; 10.1080/15384047.2017.1385678

Zhang BZ, Li MQ, Huang PZ, Guan X, Zhu YH. Overexpression of ubiquitin specific peptidase 14 predicts unfavorable prognosis in esophageal squamous cell carcinoma. Thoracic Cancer, 2017, v. 8, p. 344-349; 10.1111/1759-7714.12453

Lee VHF, Kwong DLW, Leung TW, Lam KO, Tong CC, Lee WMA. Palliative systemic therapy for recurrent or metastatic nasopharyngeal carcinoma - How far have we achieved? Critical Reviews in Oncology/Hematology, 2017, v. 114, p. 13-23; 10.1016/j.critrevonc.2017.03.030

Lam MHC, Cheuk W, Au YTK, Cheng HC, Ngan RKC. Pancreatic neuroendocrine tumours. Hong Kong Journal of Radiology, 2017, v. 20, n. 4, p. 292-302; 10.12809/hkjr1716443

Law M, Wong KK, Tso WK, Lee VHF, Luk MY, Tong CC, Chu F. Personnel dose reduction in 90Y microspheres liver-directed radioembolization: from interventional radiology suite to patient ward . The British Journal of Radiology, 2017, v. 90, p. 20160591; 10.1259/bjr.20160591

Smith C, Lee VHF, Schuessler A, Beagley L, Rehan S, Tsang WHJ, Li V, Tiu R, Smith D, Neller M, Matthews KK, Gostick E, Price DA, Burrows J, Boyle GM, Chua D, Panizza B, Porceddu SV, Nicholls J, Kwong DLW, Khanna R. Pre-emptive and therapeutic adoptive immunotherapy for nasopharyngeal carcinoma: Phenotype and effector function of T cells impact on clinical response. OncoImmunology, 2017, v. 6 n. 2, p. e1273311:1-9; 10.1080/2162402X.2016.1273311

Chiang CL, Lo SH, Agarwal A. Prognostic Factors For Survival Prediction in Advanced Cancer patients And Development of a Simple Survival Prediction Tool for Application in A Community Palliative Care Setting. In Lui LCY, Wong KW, Yeung R and Merrick J (Eds.), Palliative Care: Oncology Experience From Hong Kong, p. 91-110. Hauppauge, NY: Nova Science Publishers, 2017.

Lee VHF, Kwong DLW, Leung TW, Choi CW, Lai V, Ng L, Lam KO, Ng CY, Sze CKH, Tong CC, Ho PYP, Chan WLW, Wong LS, Kwok CLD, Chan SY, Khong PL. Prognostication of serial post-intensity-modulated radiation therapy undetectable plasma EBV DNA for nasopharyngeal carcinoma. Oncotarget, 2017, v. 8 n. 3, p. 5292-5308; 10.18632/oncotarget.14137

Li WS, Van der Velden JM, Ganesh V, Vuong S, Raman S, Popovic M, Lam H, Wong KH, Ngan R K, Maarten BJP, DeAngelis C, McDonald R, Chow E. Prophylaxis of radiation-induced nausea and vomiting: A systematic review and meta-analysis of randomized controlled trials. Annals of Palliative Medicine, 2017, v. 6, n. 2, p. 104-117; 10.21037/apm.2016.12.01

Zhang N, Fielding R, Soong SI, Chan KKL, Lee C, Ng A, Sze WK, Tsang WHJ, Lee VHF, Lam WWT. Psychometric assessment of the Chinese version of the brief illness perception questionnaire in breast cancer survivors. PLoS One, 2017, v. 12 n. 3, p. e0174093:1-10; 10.1371/journal.pone.0174093

Chiang CL, So TH, Chen ZJ, Lee VHF, Lee WMA. Pursuit of Excellence in the Management of Nasopharyngeal Carcinoma (NPC). International Journal of Head and Neck Science, 2017, v. 1 n. 4, p. 199-211; 10.6696/IJHNS.2017.0104.01

Chan OSH, Sze HC K, Lee MCH, Chan LL , Chang ATY, Lee SWM, Hung WM, Lee AWM, Ng WT. Reirradiation with intensity-modulated radiotherapy for locally recurrent T3 to T4 nasopharyngeal carcinoma. Head and Neck, 2017, v. 39, n. 3, p. 533-540; 10.1002/hed.24645

Choi CW, Xu W, Lee WMA. Reply to Nomograms need to be presented in full. Cancer, 2017, v. 123 n. 1, p. 178-179; 10.1002/cncr.30345

Fu L, Qin YR, Ming X, Zuo XB, Diao YW, Zhang L, Ai J, Liu BL, Huang TX, Cao T, Tan BB, Xiang D, Zeng CM, Gong J, Zhang Q, Dong S, Chen J, Liu H, Wu JL, Qi RZ, Xie D, Wang LD, Guan X. RNA editing of SLC22A3 drives early tumor invasion and metastasis in familial esophageal cancer. Proceedings of the National Academy of Sciences, 2017, v. 114, p. E4631-4640; 10.1073/pnas.1703178114

Lau KS, Lam KO, Chan WLW, Lee VHF, Kwong DLW, Leung TW. S-1 Versus S-1 Plus Cisplatin as First-line Treatment for Metastatic Gastric Cancer. Hong Kong Journal of Radiology, 2017, v. 20, p. 318-322; 10.12809/hkjr1716810

Sanders JJ, Chow V, Enzinger AC, Lam TC, Smith PT, Quiñones R, Baccari A, Philbrick S, White-Hammond G, Peteet J, Balboni TA, Balboni MJ. Seeking and Accepting: U.S. Clergy Theological and Moral Perspectives Informing Decision Making at the End of Life. Journal of Palliative Medicine, 2017. ; 10.1089/jpm.2016.0545

You J, Liu J, Bao Y, Wang L, Yu Y, Wang L, Wu D, Liu C, Wang N, Wang F, Wang F, Xu L, Tian X, Liang H, Gao Y, Guan R, Bai J, Meng X, Sun W, Guan X, Zhang C, Fu S, Jin Y. SEI1 induces genomic instability by inhibiting DNA damage response in ovarian cancer. Cancer Letters, 2017, v. 385, p. 271-279; 10.1016/j.canlet.2016.09.032

Tai YP, Cheung CH, Cheung KM, Cheng HC, Ngan RKC, Kwok PCH. Selective internal radiation therapy for hepatocellular carcinoma: Experience from a hospital in Hong Kong. Hong Kong Journal of Radiology, 2017, v. 20, n. 3, p. 213-219; 10.12809/hkjr1716905

Chiang CL, Lee FAS, Wong YWV, Poon CM, Choi CKK, Wong CSF, Sze WK, Tung SY. Short-course Preoperative Radiotherapy with Delayed Surgery for Locally Advanced Rectal Cancer. Hong Kong Journal of Radiology, 2017, v. 20 n. 4, p. 312-317; 10.12809/hkjr1716844

Li B, Xu W, Lam AKY, Wang YANG, Hu H-F, Guan X, Qin YR, Saremi N, Tsao GSW, He Q-Y, Cheung A. Significance of PI3K/AKT signaling pathway in metastasis of esophageal squamous cell carcinoma and its potential as a target for anti-metastasis therapy. Oncotarget, 2017, v. 8, p. 38755-38766; 10.18632/oncotarget.16333

Tang PM, Zhou S, Meng XM, Wang QM, Li CJ, Lain GY, Huang XR, Tang YJ, Guan X, Yan BP, To KF, Lan HY. Smad3 promotes cancer progression by inhibiting E4BP4-mediated NK cell development. Nature Communications, 2017, v. 8, p. 14677:1-15; 10.1038/ncomms14677

Lam MHC, Cheng HC, Ngan RKC. Stereotactic body radiation therapy for hepatocellular carcinoma: Review of a local hospital. Hong Kong Journal of Radiology, 2017, v. 20, n. 3, p. 205-212; 10.12809/hkjr1716902

Chiang CL, Yeung CSY, Wong MYP, Lee WY, Lee VHF, Lee FAS, Wong FCS. Stereotactic Body Radiotherapy for Pancreatic Cancer. Hong Kong Journal of Radiology, 2017, v. 20 n. 4, p. 303-311; 10.12809/hkjr1716861

Wong VC, Ko JMY, Lam CT, Lung ML. Succinct workflows for circulating tumor cells after enrichment: from systematic counting to mutational profiling. PLoS One, 2017, v. 12 n. 5, p. e0177276; 10.1371/journal.pone.0177276

Rotolo F, Pignon JP, Bourhis J, Marguet S, Lee WMA, Ma J, Chan ATC, Huang PY, Kwong DLW, Chau DTT. Surrogate End Points for Overall Survival in Loco-Regionally Advanced Nasopharyngeal Carcinoma: An Individual Patient Data Meta-analysis. Journal of the National Cancer Institute, 2017, v. 109 n. 4, p. djw239; 10.1093/jnci/djw239

Karam I, Yao M, Heron DE, Poon I, Koyfman SA, Yom SS, Siddiqui F, Lartigau E, Cengiz M, Yamazaki H, Hara W, Phan J, Vargo JA, Lee VHF, Foote RL, Harter KW, Lee NY, Sahgal A, Lo SS. Survey of current practices from the International Stereotactic Body Radiotherapy Consortium (ISBRTC) for head and neck cancers. Future Oncology, 2017, v. 13, p. 603-613; 10.2217/fon-2016-0403

Mui WH, Lam TC, Wong FCS, Sze WK. Survival analysis of malignant epidural spinal cord compression after palliative radiotherapy using Tokuhashi scoring system and the impact of systemic therapy. Annals of Palliative Medicine, 2017, v. 6 n. suppl. 2, p. S132-S139; 10.21037/apm.2017.07.06

Chan M, Chiang CL, Lee V, Cheung S, Leung R, Wong M, Lee F, Blanck O, Zhang QH. Target localization of 3D versus 4D cone beam computed tomography in lipiodol-guided stereotactic radiotherapy of hepatocellular carcinomas. PLoS One, 2017, v. 12, p. e0174929:1-14; 10.1371/journal.pone.0174929

Chan OSH, Lee VHF, Mok TSK, Mo F, Chang TYA, Yeung MWR. The Role of Radiotherapy in Epidermal Growth Factor Receptor Mutation-positive Patients with Oligoprogression: A Matched-cohort Analysis. Clinical Oncology, 2017, v. 29, p. 568-575; 10.1016/j.clon.2017.04.035

Chan WLW, Yuen KK, Siu SWK, Lam KO, Kwong DLW. Third-line systemic treatment versus best supportive care for advanced/metastatic gastric cancer: A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology, 2017, v. 116, p. 68-81; 10.1016/j.critrevonc.2017.05.002

Ng KY, Chan JLH, Chai S, Tong M, Guan X, Yuan Y, Xie D, Lee TK, Dusetti NJ, Carrier A, Ma SKY. TP53INP1 down-regulation activates a p73-dependent DUSP10/ERK signaling pathway to promote metastasis of hepatocellular carcinoma. Cancer Research, 2017, v. 77 n. 17, p. 4602-4612; 10.1158/0008-5472.CAN-16-3456

Ng KY, Chan LH, Chai S, Tong M, Guan XY, Lee PY, Yuan Y, Xie D, Lee TK, Dusetti NJ, Carrier A, Ma SKY. TP53INP1 downregulation activates a p73-dependent DUSP10/ERK signaling pathway to promote metastasis of hepatocellular carcinoma. Cancer Research, 2017, v. 77 n. 17, p. 4602-4612; 10.1158/0008-5472

Ho S, Ip W, Chu S, Chan S, Lee B, Chan B, Lee J, Flynn B, Ho W, Sin J, Kwong DLW, Leung TW, Lam KO. Treatment Regret in Long-term Survivors of Nasopharyngeal Carcinoma Treated with Radical Radiotherapy. Clinical Oncology, 2017, v. 29, p. e47; 10.1016/j.clon.2016.08.006

Tian BQ, Chen XJ, Zhang HH, Li XY, Wang JK, Han W, Zhang L, Fu L, Li Y, Nie CJ, Zhao Y, Tan X, Wang HL, Guan X, Hong A. Urokinase plasminogen activator secreted by cancer-associated fibroblasts induces tumor progression via PI3K/AKT and ERK signaling in esophageal squamous cell carcinoma. Oncotarget, 2017, v. 8, p. 42300-42313; 10.18632/oncotarget.15857

Chan MFT, Lam QYN, Lee VHF, Ho PYP, Sze CKH, Siu WKS, Kwong WKP, Leung TW. Using the Roach Formula to Stratify Patients with Localised Prostate Cancer Treated with Intensity-modulated Radiotherapy. Hong Kong Journal of Radiology, 2017, v. 20, p. 103-109; 10.12809/hkjr1715378

Ribassin-Majed L, Marguet S, Lee WMA, Ng WT, Ma J, Chan AT, Huang PY, Zhu G, Chua DT, Chen Y, Mai HQ, Kwong DLW, Cheah SL, Moon J, Tung Y, Chi KH, Fountzilas G, Bourhis J, Pigeon JP, Blanchard P. What Is the Best Treatment of Locally Advanced Nasopharyngeal Carcinoma? An Individual Patient Data Network Meta-Analysis. Journal of Clinical Oncology, 2017, v. 35, p. 498-505; 10.1200/JCO.2016.67.4119

Dai W, Ko JMY, Choi SSA, Yu Z, Ning L, Zheng H, Gopalan V, Chan KT, Lee NPY, Chan KW, Law SYK, Lam AKY, Lung ML. Whole-exome sequencing reveals critical genes underlying metastasis in oesophageal squamous cell carcinoma. Journal of Pathology, 2017, v. 242 n. 4, p. 500-510; 10.1002/path.4925

Shen ZY, Wang D, Ma LC, Yan H, Wong M, Lee VHF. A Computational Study of Three Frequent Mutations of EGFR and their Effects on Protein Dimer Formation and Non-Small Cell Lung Cancer Drug Resistance. Current Bioinformatics, 2016, v. 11, p. 382-391; 10.2174/1574893611666160322233746

Chow KKR, Xian Z, Liu M, Li Y, Chan HM, Song Y, Chen LL, Kwong DLW, Guan X. AKR7A3 suppresses tumorigenicity and chemoresistance in hepatocellular carcinoma through attenuation of ERK, c-Jun and NF-kB signaling pathways. Oncotarget, 2016; 10.18632/oncotarget.12726

Seow WJ, Matsuo KC, Huisung CA, Shiraishi K, Song MS, Kim HN, Wong MP, Hong YC, Hosgood HD, Wang ZM, Chang IS, Shen HB, Rothman N, Kohno T, Chanock SJ, Lan Q, Caporaso NE, Albanes D, Shin MH, Chung LP, An SJ, Berndt SL, Wang P, Zheng H, Yatabe Y, Zhang XC, Kim YT, Shu XQ, Kim YC, Bassig BA, Chang J, Ho JCM, He XZ, Ju BT, Kubo M, Daigo Y, Ito Y, Momozawa Y, Ashikawa K, KamatanI Y, Honda T, Sakamoto H, Kunitoh H, Wu W, Tsuta A K, Watanabe SI, Nokihara H, Miyagi Y, Nakayama H, Matsumoto S, Tsuboi M, Goto K, YIN ZH, SHI JX, WANG JW, Takahashi A, GOTO A, Minamiya Y, Shimizu K, Tanaka K, WU TC, Wei FS, Wong JYY, Matsuda F, Su J, LI YQ, Kim YH, Oh IJ, Song FJ, Lee VHF, Su WC, Chen YM, Chang GC, Chen KY, Huang MS, Yang PC, Choi JE, Lin HC, Xiang YB, Seow A, Park JY, Kweon SS, Chen CJ, Li HX, Gao YT, Wu C, Qian, Park, Lu D, Liu J, Jeon H, Hsiao CF, Sung JS, Tsai YH, Jung YJ, Guo H, Hu ZB, Wang WC, Sung SW, Chung CC, Lawerence C, Burdett L, Yeager M, Jacobs KB, Hutchinson A, Liu LI, Kang CH, Wang JC, Hu LM, Chen CH, Yang TY, Xu J, Guan P, Tan W, Wang CL, Sihoe ADL, Chen Y, Choi YY, Chatterjee N, Hung JY, Kim JS, Yoon HL, Cai QY, Lin CC, Park IK, Xu P, Dong J, Kim C, He QC, Tucker M, Peng RP, Chen CY, Vermeulen R, Wu JJ, Lim WY, Chen KC, Chan JKC, Chu MJ, Li YJ, Li JH, Wei H, Chen HY, Yu CJ, Jin L, Lo YL, Chen YH, Fraumeni JF, Liu J, Yamaji T, Yang Y, Hicks B, Mitsudomi T, Wyatt K, Li SA, Dai JC, Ma HX, Jin GF, Song B, Wang ZH, Chemg SS, Li XL, Ren YW, Zheng W, Cui P, Iwasaki M, Shimazu T, Tsugane S, Zhu JJ, Jiang GN, Fei K, Wu GP, Chien LH, Chen HL, Kim JH, Su YC, Tsai FY, Chen YS, Yu JM, Stevens VL, Laird-Offringa LA, Marconett CN, Lin DX, Chen K, Wu YL, Zhou BS, Landi MT. Association between GWAS-identified lung adenocarcinoma susceptibility loci and EGFR mutations in never-smoking Asian women, and comparison with findings from Western populations. Human Molecular Genetics, 2016, v. 26 n. 2, p. 454-465; 10.1093/hmg/ddw414

Ng KY, CHAI S, Tong M, Guan X, Lin C, Ching YP, Xie D, Cheng AS, Ma SKY. C-terminal truncated hepatitis B virus X protein promotes hepatocellular carcinogenesis through induction of cancer and stem cell-like properties. Oncotarget, 2016, v. 7 n. 17, p. 24005-24017.

Chow LWC, Costa L, Teh BT, Li DQ, Feng G, Guan X, Nair A, Zhu L, Sugimoto M, Dutt A, Toi M, Gupta S, Badwe R, Knapp S, Pillai MR, Kumar R. Cancer genomics and biology 2015 - Meeting report. Genes & Cancer, 2016, v. 7 n. 1-2, p. 1-6.

Qian K, Wang G, Cao R, Liu T, Qian G, Guan X, Guo Z, Xiao Y, Wang X. Capsaicin Suppresses Cell Proliferation, Induces Cell Cycle Arrest and ROS Production in Bladder Cancer Cells through FOXO3a-Mediated Pathways. Molecules, 2016, v. 21 n. 10, p. 1406; 10.3390/molecules21101406

Yang J, Lv X, Chen J, Xia W, JIANG C, Zeng T, Ye Y, Ke L, Yu Y, Liang H, Guan X, Guo X, Xiang Y. CCL2-CCR2 axis promotes metastasis of nasopharyngeal carcinoma by activating ERK1/2-MMP2/9 pathway. Oncotarget, 2016, v. 7 n. 13, p. 15632-15647; 10.18632/oncotarget.6695

Li J, Chen J, Zeng TT, He F, Chen SP, Ma SKY, Bi J, Zhu XF, Guan X. CD133+ liver cancer stem cells resist interferon-gamma induced autophagy. BMC Cancer, 2016, v. 16, p. 15; 10.1186/s12885-016-2050-6

Li J, Zhang BZ, Qin YR, Bi J, Liu HB, Li Y, Ma SKY, Chan KW, Xie D, Guan X. CD68 and interleukin 13, prospective immune markers for esophageal squamous cell carcinoma prognosis prediction. Oncotarget, 2016, v. 7 n. 13, p. 15525-15538; 10.18632/oncotarget.6900

Keefe D, AI Garni A, Villalon A, Hassan A, Kwong DLW, Li P, Tamura K, Kim JH, Yusof MM, Javed MZ, Kanesvaran R, Hsieh RK, Aapro M. Challenges in supportive cancer care: perspectives from the Asia Pacific and Middle East. Supportive Care in Cancer, 2016, v. 24, p. 4479-4481; 10.1007/s00520-016-3381-1

Tang Z, CAO T, Lin S, Fu L, Li S, Guan X, Cai Z. Characterization of oncogene-induced metabolic alterations in hepatic cells by using ultrahigh performance liquid chromatography-tandem mass spectrometry.. Talanta, 2016, v. 152, p. 119-126.

Liu M, Chow KKR, Li Y, Guan X. CHD1L promotes lineage reversion of hepatocellular carcinoma through opening chromatin for key developmental transcription factors. Hepatology, 2016, v. 63 n. 5, p. 1544-1559; 10.1002/hep.28437

Chan WLW, Lam KO, Siu WKS, Yuen KK. Chemotherapy at end-of-life: an integration of oncology and palliative team. Supportive Care in Cancer, 2016, v. 24 n. 3, p. 1421-1427; 10.1007/s00520-015-3031-z

Li CP, Cai MY, Jiang LJ, Mai SJ, Chen JW, Wang FW, Liao YJ, Chen WH, Jin XH, Pei XQ, Guan X, Zeng MS, Xie D. CLDN14 is epigenetically silenced by EZH2-mediated H3K27ME3 and is a novel prognostic biomarker in hepatocellular carcinoma.. Carcinogenesis, 2016, v. 37 n. 6, p. 557-566.

Li B, Xu W, Guan X, Qin YR, Law SYK, Lee NPY, Chan KT, Tam PY, Li YY, Chan KW, Yuen HF, Tsao GSW, He QY, Cheung A. Competitive Binding Between Id1 and E2F1 to Cdc20 Regulates E2F1 Degradation and Thymidylate Synthase Expression to Promote Esophageal Cancer Chemoresistance. Clinical Cancer Research, 2016, v. 22 n. 5, p. 1243-1255; 10.1158/1078-0432.CCR-15-1196

Lee VHF, Lo AW, Leung CY, Shek WH, Kwong DLW, Lam KO, Tong CC, Sze CKH, Leung TW. Correlation of PD-L1 Expression of Tumor Cells with Survival Outcomes after Radical Intensity-Modulated Radiation Therapy for Non-Metastatic Nasopharyngeal Carcinoma. PLoS One, 2016, v. 11 n. 6, p. article no. e0157969; 10.1371/journal.pone.0157969

Cao R, Meng Z, Liu T, Wang G, Qian G, Guan X, Dan H, Xiao Y, Wang X. Decreased TRPM7 inhibits activities and induces apotosis of bladder cancer cells via ERK1/2 pathway. Oncotarget, 2016, v. 7 n. 45, p. 72941-72960; 10.18632/oncotarget.12146

Ng HY, Ko JMY, Yu Z, Ip JCY, Dai W, Cal S, Lung ML. DESC1, a novel tumor suppressor, sensitises cells to apoptosis by down-regulating the EGFR/AKT pathway in esophageal squamous cell carcinoma. International Journal of Cancer, 2016, v. 138, p. 2940-2951; 10.1002/ijc.30034

Lee VHF, Chan SY, Choi CW, Kwong DLW, Lam KO, Tong CC, Sze CKH, Leung TW, Ng S, Lee WMA. Dosimetric Predictors of Hypothyroidism After Radical Intensity-modulated Radiation Therapy for Non-metastatic Nasopharyngeal Carcinoma. Clinical Oncology, 2016, v. 28 n. 8, p. e52-e60; 10.1016/j.clon.2016.05.004

Lee VHF, Leung DKC, Choy TS, Lam KO, Lam PM, Leung TW, Kwong DLW. Efficacy and safety of afatinib in Chinese patients with EGFR-mutated metastatic non-small-cell lung cancer (NSCLC) previously responsive to first-generation tyrosine-kinase inhibitors (TKI) and chemotherapy: comparison with historical cohort using erlotinib. BMC Cancer, 2016, v. 16, article no. 147; 10.1186/s12885-016-2201-9

Wong WK, Leung LH, Kwong DLW. Evaluation and optimization of the parameters used in multiple-atlas-based segmentation of prostate cancers in radiation therapy. British Journal of Radiology, 2016, v. 89 n. 1057, p. article no. 20140732; 10.1259/bjr.20140732

Huang PY, Zeng T, Ban X, Li MQ, Zhang BZ, Zhu YH, Hua WF, Mai HQ, Zhang L, Guan X, Li Y. Expression of EIF5A2 associates with poor survival of nasopharyngeal carcinoma patients treated with induction chemotherapy. BMC Cancer, 2016, v. 16, p. 669:1-9; 10.1186/s12885-016-2714-2

Dai W, ZHENG H, Cheung AKL, Lung ML. Genetic and epigenetic landscape of nasopharyngeal carcinoma. Chinese Clinical Oncology, 2016, v. 5 n. 2, article no. 16; 10.21037/cco.2016.03.06

Lam KO, Lee AWM, Choi CW, Sze HCK. Global Pattern of Nasopharyngeal Cancer: Correlation of Outcome With Access to Radiation Therapy. International Journal of Radiation Oncology - Biology - Physics, 2016, v. 94 n. 5, p. 1106-1112; 10.1016/j.ijrobp.2015.11.047

Lee VHF. How far have we achieved by systemic therapy for recurrent/metastatic nasopharyngeal carcinoma? Translational Cancer Research, 2016, v. 5 n. suppl. 7, p. S1424-S1427; 10.21037/tcr.2016.12.25

Phoon YP, Cheung AKL, Cheung FMF, Chan KF, Wong S, Wong WY, Tung SY, Yau CC, Ng WT, Lung ML. IKBB tumor suppressive role in nasopharyngeal carcinoma via NF-kB-mediated signalling . International Journal of Cancer, 2016, v. 138, p. 160-170; 10.1002/ijc.29702

Zhang N, Fielding R, Soong I, Chan KKL, Tsang WHJ, Lee VHF, Lee C, Ng A, Sez WK, Tin SPP, Lam WWT. Illness perceptions among cancer survivors. Supportive Care in Cancer, 2016, v. 24 n. 3, p. 1295-1304; 10.1007/s00520-015-2914-3

Xu L, Li X, Cai M, Chen J, Li X, Wu WK, Kang W, Tong J, To KF, Guan X, Sung JJ, Chan FK, Yu J. Increased expression of Solute carrier family 12 member 5 via gene amplification contributes to tumour progression and metastasis and associates with poor survival in colorectal cancer. Gut, 2016, v. 65 n. 4, p. 635-646; 10.1136/gutjnl-2014-308257

Hui KF, Cheung AKL, Choi CK, Yeung PL, Middeldorp JM, Lung ML, Tsao GSW, Chiang AKS. Inhibition of class I histone deacetylases by romidepsin potently induces Epstein-Barr virus lytic cycle and mediates enhanced cell death with ganciclovir. International Journal of Cancer, 2016, v. 138 n. 1, p. 125-136; 10.1002/ijc.29698

Ming XY, Fu L, Zhang LY, Qin YR, Cao TT, Chan KW, Ma S, Xie D, Guan XY. Inegrin α7 is a functional cancer stem cell surface marker in oesophageal squamous cell carcinoma. Nature Communication 2016; 10.1038/ncomms13568

Ng WT, Bernier J, Ngan RKC, Chan OSH, Sze CKH, Chan JYW, Lee WMA. Management of nasopharyngeal carcinoma. In Bernier, J (Ed.), Head and Neck Cancer: Multimodality Management (2nd ed.), p. 445-473. Switzerland: Springer, 2016; 10.1007/978-3-319-27601-4_26

Bao Y, Liu J, You J, Wu D, Yu Y, Liu C, Wang L, Wang F, Xu L, Wang L, Wang N, Tian X, Wang F, Liang H, Gao Y, Cui X, Ji G, Bai J, Yu J, Meng X, Jin Y, Sun W, Guan X, Zhang C, Fu S. Met promotes the formation of double minute chromosomes induced by Sei-1 in NIH-3T3 murine fibroblasts. Oncotarget, 2016, v. 7 n. 35, p. 56664-56675; 10.18632/oncotarget.10994

Chai WY, Cheung AKL, Dai W, Ko JMY, Ip JCY, Chan KW, Kwong DLW, Ng WT, Lee WMA, Ngan KC, Yau CC, Tung SY, Lee VHF, Lam AKY, Pillai S, Law SYK, Lung ML. Metastasis-suppressing NID2, an epigenetically silenced gene, in the pathologenesis of nasopharyngeal carcinoma and esophageal squamous cell carcinoma. Oncotarget, 2016, v. 7 n. 48, p. 78859-78871; 10.18632/oncotarget.12889

Fung TM, Ng KY, Tong M, CHEN J, Chai S, Chan KT, Law SYK, Lee NPY, Choi MY, Li B, Cheung A, Tsao GSW, Qin YR, Guan X, Chan KW, Ma SKY. Neuropilin-2 promotes tumourigenicity and metastasis in oesophageal squamous cell carcinoma through ERK-MAPK-ETV4-MMP-E-cadherin deregulation. Journal of Pathology, 2016, v. 239 n. 3, p. 309-319; 10.1002/path.4728

Chai S, Ng KY, Tong M, Lau EY, Lee TK, Chan KW, Yuan YF, Cheung TT, Cheung ST, Wang X, Wong N, Lo CM, Man K, Guan X, Ma SKY. Octamer 4/microRNA-1246 signaling axis drives Wnt/β-catenin activation in liver cancer stem cells. Hepatology, 2016, v. 64 n. 6, p. 2062-2076; 10.1002/hep.28821

Li XD, Zhang JX, Jiang LJ, Wang FW, Liu LL, Laio YJ, Jin XH, Chen WH, Chen X, Guo SJ, Zhou FJ, Zeng YX, Guan X, Liu ZW, Xie D. Overexpression of maelstrom promotes bladder urothelial carcinoma cell aggressiveness by epigenetically down-regulating MTSS1 through DNMT3B. Oncogene, 2016, v. 35, p. 6281-6292; 10.1038/onc.2016.165

Lyu Z, Wu S, Cai Z, Guan X. Patient-physician trust in China: health education for the public. The Lancet, 2016, v. 388, p. 2991; 10.1016/S0140-6736(16)32521-1

So TH, Ho PYP, Leung TW, Kwong DLW. Pneumocystis Jiroveci Infection and Craniospinal Irradiation with Arc Therapy: a Report of Two cases. Hong Kong Journal of Radiology, 2016, v. 19 n. 2, p. 126-131; 10.12809/hkjr1615329

Lee VHF, Kwong DLW, Leung TW, Choi CW, Lam KO, Sze CKH, Ho PYP, Chan WLW, Wong LS, Leung D. Post-radiation Plasma Epstein-Barr Virus DNA and Local Clinical Remission After Radical Intensity-modulated Radiation Therapy for Nasopharyngeal Carcinoma. Clinical Oncology, 2016, v. 28 n. 1, p. 42-49; 10.1016/j.clon.2015.09.009

Pan JJ, Ng WT, Zong JF, Lee SW, Choi HC, Chan LL, Lin SJ, Guo QJ, Sze HC, Chen YB, Xiao YP, Kan WK, O'Sullivan B, Xu W, Le QT, Glastonbury CM, Colevas AD, Weber RS, Lydiatt W, Shan JP, Lee WMA. Prognostic nomogram for refining the prognostication of the proposed 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy. Cancer, 2016, v. 122 n. 21, p. 3307-3315; 10.1002/cncr.30198

Lee VHF, Chan WLW, Lee EYP, Choy TS, Ho PP, Leung DK, Lam KO, Kwong DLW, Leung TW, Khong PL. Prognostic Significance of Standardized Uptake Value of Lymph Nodes on Survival for Stage III Non-Small Cell Lung Cancer Treated With Definitive Concurrent Chemoradiotherapy. American Journal of Clinical Oncology, 2016, v. 39 n. 4, p. 355-362; 10.1097/COC.0000000000000070

Pan JJ, Ng WT, Zong JF, Chan LLK, O'Sullivan B, Lin SJ, Sze HCK, Chen YB, Choi HCW, Guo QJ, Kan WK, Xiao YP, Wei X, Le QT, Glastonbury CM, Colevas AD, Weber RS, Shah JP, Lee AWM. Proposal for the 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy. Cancer, 2016, v. 122 n. 4, p. 546-558; 10.1002/cncr.29795

Zhang L, Wu JL, Qiu HB, Dong SS, Zhu YH, Lee VHF, Qin YR, Li Y, Chen J, Liu HB, Bi J, Ma SKY, Guan X, Fu L. PSCA acts as a tumor suppressor by facilitating the nuclear translocation of RB1CC1 in esophageal squamous cell carcinoma. Carcinogenesis, 2016, v. 37 n. 3, p. 320-332; 10.1093/carcin/bgw010

V. Lee, Sum YC, Cheuk WC, D. Kwong, Lam KO, Tong CC, Sze CK, S. Ng, Leung TW, A. Lee. Dosimetric Predictors of Hypothyroidism After Radical Intensity-modulated Radiation Therapy for Non-metastatic Nasopharyngeal Carcinoma. Clinical Oncology (Royal College of Radiologists). 2016;28(8):e52-60

Ma WH, Ng S, Ho WY, Lam M, Lee VHF, Wong KK, Tso WK. Radiation Dosimetry in Selective Internal Radiation Treatment in Patients with Portosystemic Shunts to Umbilical Veins. Hong Kong Journal of Radiology, 2016, v. 19, p. 137-140; 10.12809/hkjr1615351

Lee VHF, Lam KO, Kwong DLW, Leung TW. Radiation recall after capecitabine in a patient with recurrent nasopharyngeal carcinoma: a case report. Journal of Medical Case Reports, 2016, v. 10, p. 247:1-4; 10.1186/s13256-016-1033-1

Lee FAS, Zee BCY, Cheung FY, Kwong P, Chiang CL, Leung KC, Siu SWK, Lee C, Lai M, Kwok C, Chong M, Jolivet J, Tung S. Randomized Phase II Study of the X-linked Inhibitor of Apoptosis (XIAP) Antisense AEG35156 in Combination with Sorafenib in Patients with Advanced Hepatocellular Carcinoma (HCC). American Journal of Clinical Oncology: Cancer Clinical Trials, 2016, v. 39, n. 6, p. 609-613; 10.1097/COC.0000000000000099

Tang H, Wu Y, Qin Y, Wang H, Wang L, Guan X, Luo S, Wang Q. Reduction of AZGP1 predicts poor prognosis in esophageal squamous cell carcinoma patients in northern China. OncoTargets and Therapy, 2016, v. 10, p. 85-94; 10.2147/OTT.S113932

Lin SH, Liu T, Ming X, Tang Z, Fu L, Schmitt-Kopplin P, Kanawati B, Guan X, Cai Z. Regulatory role of hexosamine biosynthetic pathway on hepatic cancer stem cell marker CD133 under low glucose conditions. Scientific Reports, 2016, v. 6, p. 21184:1-10; 10.1038/srep21184

Li J, Li B, Xu WW, Chan KW, Guan XY, Qin YR, Lee NPY, Chan KT, Law SYK, Tsao GSW, Cheung A. Role of AMPK signaling in mediating the anticancer effects of silibinin in esophageal squamous cell carcinoma. Expert Opinion On Therapeutic Targets, 2016, v. 20 n. 1, p. 7-18; 10.1517/14728222.2016.1121236

Pow EHN, Chen Z, Kwong DLW, Lam OLT. Salivary Anionic Changes after Radiotherapy for Nasopharyngeal Carcinoma: A 1-Year Prospective Study. PLoS ONE, 2016, v. 11, p. e0152817; 10.1371/journal.pone.0152817

Wang DD, Lee VHF, Zhu GY, Zou B, Ma LC, Yan H. Selectivity profile of afatinib for EGFR-mutated non-small-cell lung cancer. Mol. BioSyst., 2016, v. 12, p. 1552-1563; 10.1039/C6MB00038J

Zhu D, Zhang J, Deng W, Yip YL, Lung HL, Tsang CM, Law WT, Yang J, Lau MY, Lung ML, Cheung A, Tsao GSW. Significance of NF-kB activation in immortalization of nasopharyngeal epithelial cells. International Journal of Cancer, 2016, v. 138 n. 5, p. 1175-1185; 10.1002/ijc.29850

Nicholls J, Chan M, Kwong DLW. Susceptibility of the upper respiratory tract to influenza virus infection following desialylation. Hong Kong Medical Journal, 2016, v. 22 n. 3 Suppl. 4, p. 7-9.

Lee VHF. The aftermath of LUX-Lung 7 study: what have we learnt from it? Annals of Translational Medicine, 2016, v. 4 n. 15, p. 294:1-3; 10.21037/atm.2016.07.02

Lam KO, Lee AWM, Ng WT, Hopkins KI. The International Atomic Energy Agency global initiatives on nasopharyngeal cancer treatment. Chinese Clinical Oncology, 2016, v. 5 n. 2, p. article no. 27; 10.21037/cco.2016.03.02

Stunnenberg HG, Hirst M, Abrignani S, Adams D, de Almeida M, Altucci L, Amin V, Amit I, Antonarakis SE, Aparicio S, Arima T, Arrigoni L, Arts R, Asnafi V, Esteller M, Bae JB, Bassler K, Beck S, Berkman B, Bernstein BE, Bilenky M, Bird A, Bock C, Boehm B, Bourque G, Breeze CE, Brors B, Bujold D, Burren O, Bussemakers MJ, Butterworth A, Campo E, Carrillo-de-Santa-Pau E, Chadwick L, Chan KM, Chen W, Cheung TH, Chiapperino L, Choi NH, Chung HR, Clarke L, Connors JM, Cronet P, Danesh J, Dermitzakis M, Drewes G, Durek P, Dyke S, Dylag T, Eaves CJ, Ebert P, Eils R, Eils J, Ennis CA, Enver T, Feingold EA, Felder B, Ferguson-Smith A, Fitzgibbon J, Flicek P, Foo RS, Fraser P, Frontini M, Furlong E, Gakkhar S, Gasparoni N, Gasparoni G, Geschwind DH, Glažar P, Graf T, Grosveld F, Guan XY, Guigo R, Gut IG, Hamann A, Han BG, Harris RA, Heath S, Helin K, Hengstler JG, Heravi-Moussavi A, Herrup K, Hill S, Hilton JA, Hitz BC, Horsthemke B, Hu M, Hwang JY, Ip NY, Ito T, Javierre BM, Jenko S, Jenuwein T, Joly Y, Jones SJM, Kanai Y, Kang HG, Karsan A, Kiemer AK, Kim SC, Kim BJ, Kim HH, Kimura H, Kinkley S, Klironomos F, Koh IU, Kostadima M, Kressler C, Kreuzhuber R, Kundaje A, Küppers R, Larabell C, Lasko P, Lathrop M, Lee DHS, Lee S, Lehrach H, Leitão E, Lengauer T, Lernmark Å, Leslie RD, Leung GKK, Leung D, Loeffler M, Ma Y, Mai A, Manke T, Marcotte ER, Marra MA, Martens JHA, Martin-Subero JI, Maschke K, Merten C, Milosavljevic A, Minucci S, Mitsuyama T, Moore RA, Müller F, Mungall AJ, Netea MG, Nordström K, Norstedt I, Okae H, Onuchic V, Ouellette F, Ouwehand W, Pagani M, Pancaldi V, Pap T, Pastinen T, Patel R, Paul DS, Pazin MJ, Pelicci PG, Phillips AG, Polansky J, Porse B, Pospisilik JA, Prabhakar S, Procaccini DC, Radbruch A, Rajewsky N, Rakyan V, Reik W, Ren B, Richardson D, Richter A, Rico D, Roberts DJ, Rosenstiel P, Rothstein M, Salhab A, Sasaki H, Satterlee JS, Sauer S, Schacht C, Schmidt F, Schmitz G, Schreiber S, Schröder C, Schübeler D, Schultze JL, Schulyer RP, Schulz M, Seifert M, Shirahige K, Siebert R, Sierocinski T, Siminoff L, Sinha A, Soranzo N, Spicuglia S, Spivakov M, Steidl C, Strattan JS, Stratton M, Südbeck P, Sun H, Suzuki N, Suzuki Y, Tanay A, Torrents D, Tyson FL, Ulas T, Ullrich S, Ushijima T, Valencia A, Vellenga E, Vingron M, Wallace C, Wallner S, Walter J, Wang H, Weber S, Weiler N, Weller A, Weng A, Wilder S, Wiseman SM, Wu AR, Wu Z, Xiong J, Yamashita Y, Yang X, Yap DY, Yip KY, Yip S, Yoo JI, Zerbino D, Zipprich G. The International Human Epigenome Consortium: A Blueprint for Scientific Collaboration and Discovery. Cell, 2016, v. 167, p. 1145-1149. ; 10.1016/j.cell.2016.11.007

Lam KO, Lee KC, Chiu WYJ, Lee VHF, Leung RCY, Choy TS, Yau TCC. The Real-World Use of Regorafenib for Metastatic Colorectal Cancer: Multicentre Analysis of Treatment Pattern and Outcomes in Hong Kong. Postgraduate Medical Journal, 2016; 10.1136/postgradmedj-2016-134547

Dai W, Zheng H, Cheung AKL, Tang SM, Ko JMY, Wong WY, Leong ML, Sham PC, Cheung MFF, Kwong DLW, Ngan KC, Ng WT, Yau CC, Chiang AKS, Lee WMA, Lee VHF, Lam KO, Au GKH, Lung ML. Whole-exome sequencing identifies MST1R as a genetic susceptibility gene in nasopharyngeal carcinoma. Proceedings of the National Academy of Sciences, 2016, v. 113 n. 12, p. 3317-3322; 10.1073/pnas.1523436113

Zheng H, Dai W, Cheung AKL, Ko JMY, Kan PQR, Wong WY, Leong ML, Deng M, Kwok CTT, Chan YW, Kwong DLW, Lee WMA, Ng WT, Ngan RKC, Yau CC, Tung S, Lee VHF, Lam KO, Kwan CK, Li WS, Yau S, Chan KW, Lung ML. Whole-exome sequencing identifies multiple loss-of-function mutations of NF-kB pathway regulators in nasopharyngeal carcinoma. Proceedings of the National Academy of Sciences of the United States of America, 2016, v. 113, n. 40, p. 11283-11288; 10.1073/pnas.1607606113

Yuan C, Yip SP, Wu VW, Kwong DL, Cheuk IW, Ying M. Association between genetic polymorphisms and carotid atherosclerosis in patients treated with radiotherapy for nasopharyngeal carcinoma. Radiat Oncol. 2015;10:39.

Yuan C, Wu VW, Yip SP, Kwong DL, Ying M. Ultrasound Evaluation of Carotid Atherosclerosis in Post-Radiotherapy Nasopharyngeal Carcinoma Patients, Type 2 Diabetics, and Healthy Controls. Ultraschall Med. 2017 Apr;38(2):190-197.

Yu VZ, Wong VCL, Mun-Yee Ko JMY, Lam AKY, Chan KW, Samant R, Hong Lok Lung HL, Dai W, Shuen WH, Law S, Chan YP, Lee NPY, Tong DKH, Law TT, Lee VHF, Li Lung M. Nuclear DNAJB6, a good independent prognostic marker for survival of late-onset metastasis-free esophageal cancer patients, modulates Akt signaling and suppresses cancer cell proliferation. Gastroenterology. 2015;149(7):1825-1836

Yang X, Dai W, Kwong DL, Szeto CYY, Wong EH, Ng WT, Lee AWM, Ngan RKC, Yau CC, Tung SY, Lung ML. Epigenetic markers for non-invasive early detection of nasopharyngeal carcinoma by methylation-sensitive high resolution melting. IJC. 2015;136(4):E127-35

Wang DD, Ma LC, Wong MP, Lee VHF, Yan H. Contribution of EGFR and ErbB-3 heterodimerization to the EGFR mutation-induced gefitinib- and erlotinib-resistance in non-small-cell lung carcinoma treatments. PLoS One. 2015;10(5):e0128360.

Sze HCK, Lee AWM, Blanchard P, Ng WT, Pignon JP. Chemotherapy for Nasopharyngeal Carcinoma – Current Recommendation and Controversies. Hematology/Oncology Clinics of North America. 2015;29:1107-1122

Strojan P, Vermorken JB, Beitler JJ, Saba NF, Haigentz M Jr, Bossi P, Worden FP, Langendijk JA, Eisbruch A, Mendenhall WM, Lee AWM, Harrison LB, Bradford CR, Smee R, Silver CE, Rinaldo A, Ferlito. Cumulative cisplatin dose in concurrent chemoradiotherapy for head and neck cancer: a systematic review. Head Neck. 2016;Suppl 1:E2151-8

Strojan P, Corry J, Eisbruch A, Vermorken JB, Mendenhall WM, Lee AWM, Haigentz M Jr, Beitler JJ, de Bree R, Takes RP, Paleri V, Kelly CG, Genden EM, Bradford CR, Harrison LB, Rinaldo A, Ferlito A. Recurrent and Second Primary Squamous Cell Carcinoma of the Head And Neck: When and How to Re-Irradiate. Head & Neck. 2015;37(1):134-150

Seneviratne CJ, Fong PHL, Wong SSW, Lee VHF. Antifungal susceptibility and phenotypic characterization of oral isolates of a black fungus from a nasopharyngeal carcinoma patient under radiotherapy. BMC Oral Health. 2015;15:39

Ng WT, Chang AT, Lee SW, Sze HC, Lee AW. * Chemotherapy for Nasopharyngeal Cancer: Neoadjuvant, Concomitant, and/or Adjuvant. Curr Treat Options Oncol. 2015;16(9):361

Ma LC, Wang DD, Huang YQ, Yan H, Wong MP, Lee VHF. EGFR Mutant Structural Database: Computationally predicted 3D structures and the corresponding binding free energies with gefitinib and erlotinib. BMC Bioinformatics. 2015;16:85

Lung HL, Man OY, Yeung MC, Ko JM, Cheung AK, Law EW, Yu Z, Shuen WH, Tung E, Chan SH, Bangarusamy DK, Cheng Y, Yang X, Kan R, Phoon Y, Chan KC, Chua D, Kwong DL, Lee AW, Ji MF, Lung ML. SAA1 polymorphisms are associated with variation in antiangiogenic and tumor-suppressive activities in nasopharyngeal carcinoma. Oncogene. 2015;34(7):878-89.

Li JY, Pow EH, Zheng LW, Ma L, Kwong DL, Cheung LK. Effects of calcium phosphate nanocrystals on osseointegration of titanium implant in irradiated bone. Biomed Res Int. 2015;2015:783894.

Lee VHF, Fang WJ, Lam KO, Choi CW, Ng SCY, Ho GCL, Cheng TKC, Ho PPY, Liu RKY, Leung TW, Kwong DLW, Zheng SS. Impact of CAPOX or FOLFOX on spleen size, platelet count and liver function when partnered cetuximab as first-line treatment for KRAS wild-type metastatic colorectal cancer. Cancer Research Frontiers. 2015;1(1): 60-74

Lee VHF , Leung DKC, Choy TS, Lam KO, Choi HY, Lam PM, Hui CYT, Leung TW, Kwong DLW. Efficacy and safety of afatinib in Chinese patients with EGFR-mutated metastatic non-small cell lung cancer previously responsive to 1st generation tyrosine-kinase inhibitors and chemotherapy: comparison with historical cohort using erlotinib in the same setting. Lung Cancer. 2016;16:147

Lee VHF , Kwong DLW, Leung TW, Choi CW, Lam KO, Sze HCK, Ho PPY, Chan WL, Wong LS, Leung DKC, Chan SY, Chan FT. Postradiation plasma EBV DNA and local clinical remission after radical intensity-modulated radiation therapy for nasopharyngeal carcinoma. Radiother Oncol. 2015;28(1):42-9

Lee VHF (first and corresponding author), Leung DKC, Luk MY, Tong CC, Law MWM, Ng SCY, Tso WK, Wong KK, Liu RKY, Roon RTP, Kwong DLW, Leung TW. Yttrium-90 Radioembolization for Advanced Inoperable Hepatocellular Carcinoma. Asian Pac J Cancer Prev. 2015;8:3457-64

Lee EYP, Khong PL, Lee VHF, Qian WS, Wong MP. Metabolic phenotype of stage IV lung adenocarcinoma: relationship with epidermal growth factor receptor mutation. Clin Nucl Med. 2015;40(3):e190-195.

Lee A, Ngan R, Tung S, Cheng A, Kwong D, Lu TX, Chan A, Chan L, Yiu H, Ng WT, Wong F, Yuen KT, Yau S, Cheung FY, Chan O, Choi H, Chappell R. Preliminary Results of NPC-0501 Trial to Evaluate the Therapeutic Gain by Changing Chemoradiotherapy Sequence from Concurrent-Adjuvant to Induction-Concurrent, Fluorouracil to Capecitabine, and Radiotherapy Fractionation from Conventional to Accelerated for Locoregionally Advanced Nasopharyngeal Carcinoma. Cancer. 2015; 121:1328-38

Kan R, Shuen WH, Lung HL, Cheung AKL, Dai W, Kwong DLW, Ng WT, Lee AWM, Yau CC, Ngan RKC, Tung SY, Lung ML. NF-κB p65 Subunit Is Modulated by Latent Transforming Growth Factor-β Binding. PLOS ONE. 2015;10(5): e0127239

Hui EP, Ma BBY, Chan KCA, Chan CML, Wong CSC, To KF, Chan AWH, Tung SY, Ng WT, Cheng AC, Lee VHF, Chan SL, Loong HHF, Kam MKM, Leung SF, Ho R, Mo F, Lo DYM, Ngan RKC, Chan ATC. Clinical utility of plasma EBV DNA andERCC1 single nucleotide polymorphism in nasopharyngeal carcinoma. Cancer. 2015;121(16):2720-9

Huang B, Wong CY, Lai V, Kwong DL, Khong PL. Prognostic Value of (18) F-FDG PET-CT in Nasopharyngeal Carcinoma: Is Dynamic Scanning Helpful? Biomed Res Int. 2015;2015:582614.

Dai W, Cheung AKL, Ko JMY, Cheng Y, Zheng H, Ngan RKC, Ng WT, Lee AWM, Yau CC, Lee VHF, Li Lung M. Comparative Methylome Analysis in Solid Tumours Reveals Aberrant Methylation at Chromosome 6p in Nasopharyngeal Carcinoma. Cancer Med. 2015 Jul;4(7):1079-90

Chen J, Kwong DL, Cao T, Hu Q, Zhang L, Ming X, Chen J, Fu L, Guan X. Esophageal squamous cell carcinoma (ESCC): advance in genomics and molecular genetics. Dis Esophagus. 2015; 28 (1): 84-9.

Chan MK, Kwong DL, Lee VW, Leung RW, Wong MY, Blanck O. Feasibility study of robotic hypofractionated lung radiotherapy by individualized internal target volume and XSight Spine Tracking: a preliminary dosimetric evaluation. J Cancer Res Ther. 2015;11(1):150-7.

Chan KC, Chan LS, Ip JCY, Lo C, Yip TTC, Ngan RKC, Wong RNS, Lo KW, Ng WT, Lee AWM, Tsao GSW, Kahn M, Lung ML, Mak NK. Therapeutic targeting of CBP/b-catenin signaling reduces cancer stem-like population and synergistically suppresses growth of EBV-positive nasopharyngeal carcinoma cells with cisplatin. Scientific Reports. 2015; 5:9979

Blanchard P, Lee A, Marguet S, Leclercq J, Ng WT, Ma J, Chan AT, Huang PY, Benhamou E, Zhu G, Chua DT, Chen Y, Mai HQ, Kwong DL, Cheah SL, Moon J, Tung Y, Chi KH, Fountzilas G, Zhang L, Hui EP, Lu TX, Bourhis J, Pignon JP; MAC-NPC Collaborative Group. Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis. Lancet Oncol. 2015;16(6):645-55.

AWM Lee, B Ma, WT Ng, ATC Chan. The management of nasopharyngeal carcinoma – current practice and future perspective. JCO. 2015; 33. 3356-3364

Yuan C, Wu VW, Yip SP, Kwong DL, Ying M. Predictors of the extent of carotid atherosclerosis in patients treated with radiotherapy for nasopharyngeal carcinoma. PLoS One. 2014;9(12):e116284.

Ko JMY, Dai W, Wong EHW, Kwong D, Ng WT, Lee A, Ngan RKC, Yau CC, Tung S, Lung ML. Multigene pathway-based analyses identify nasopharyngeal carcinoma risk associations for cumulative adverse effects of TERT-CLPTM1L and DNA double-strand breaks repair. Int J Cancer. 2014;135(7):1634-45.

Wong KW, Kwong DLW, Khong PL, Lee VHF, Ng SCY, Law MWM. Delineation of biological tumor volume from positron emission tomography images in nasopharyngeal carcinoma. J. Biomedical Science and Engineering. 2014;7:857-865.

Tsang JWH, Lee VHF, Kwong DLW. Novel therapy for nasopharyngeal carcinoma – Where are we. Oral Oncol. 2014;50(9):798-801.

Sze H, Chan LLK. , Ng WT, Hung AWM, Lee MCH, Chang ATY, Chan OSH, Cheung FY, Yeung RMW, Lee AWM. Should all nasopharyngeal carcinoma with masticator space involvement be staged as T4? Oral Oncol. 2014; 50:1188–1195

Sun Y, Yu XL, Lee AWM, Wee JTS, Lee N Zhou GQ, Tang LL, Tao CJ, Guo R, Mao YP, Zhang R, Guo Y, Ma J. Recommendation for a Contouring Method and Atlas of Organs at Risk in Nasopharyngeal Carcinoma Patients Receiving Intensity-Modulated Radiotherapy. Radiother Oncol. 2014;110(3):390-397

Shan J, Pow EH, Tsang PC, Perera RA, Kwong DL. Comparison of two laboratory extraction techniques for the detection of Epstein-Barr virus in the saliva of nasopharyngeal carcinoma patients. J Investig Clin Dent. 2014;5(2):104-8.

Ng WT, Yuen KT, Au KH, Chan OSH, Lee AWM. Staging of Nasopharyngeal Carcinoma - The Past, The Present and The Future. Oral Oncol. 2014;50(6):549-554

Ng WT, Lee MCH, Chang ATY, Chan OSH, Chan LLK, Cheung FY, Hung WM, Chan CC, Lee AWM. The Impact of Dosimetric Inadequacy on Treatment Outcome of Nasopharyngeal Carcinoma with IMRT. Oral Oncol. 2014;50(5):506-512

Mok TS, Geater SL, Iannotti N, Thongprasert S, Spira A, Smith D, Lee V, Lim WT, Reyderman L, Wang B, Gopalakrishna P, Garzon F, Xu L, Reynolds C. Randomised phase II study of two intercalated combinations of eribulin mesilate and erlotinib in patients previously pretreated advanced non-small cell lung cancer. Ann Oncol. 2014;25(8):1578-84.

Machiela MJ, Hsiung CA, Shu XO, Seow WJ, Wang Z, Matsuo K, Hong YC, Seow A, Wu C, Hosgood HD 3rd, Chen K, Wang JC, Wen W, Cawthon R, Chatterjee N, Hu W, Caporaso NE, Park JY, Chen CJ, Kim YH, Kim YT, Landi MT, Shen H, Lawrence C, Burdett L, Yeager M, Chang IS, Mitsudomi T, Kim HN, Chang GC, Bassig BA, Tucker M, Wei F, Yin Z, An SJ, Qian B, Lee VH, Lu D, Liu J, Jeon HS, Hsiao CF, Sung JS, Kim JH, Gao YT, Tsai YH, Jung YJ, Guo H, Hu Z, Hutchinson A, Wang WC, Klein RJ, Chung CC, Oh IJ, Chen KY, Berndt SI, Wu W, Chang J, Zhang XC, Huang MS, Zheng H, Wang J, Zhao X, Li Y, Choi JE, Su WC, Park KH, Sung SW, Chen YM, Liu L, Hyun Kang C, Hu L, Chen CH, Pao W, Kim YC, Yang TY, Xu J, Guan P, Tan W, Su J, Wang CL, Li H, Dart Loon Sihoe A, Zhao Z, Chen Y, Choi YY, Hung JY, Kim JS, Yoon HI, Cai Q, Lin CC, Park IK, Xu P, Dong J, Kim C, He Q, Perng RP, Kohno T, Kweon SS, Chen CY, Vermeulen RC, Wu J, Lim WY, Chen KC, Chow WH, Ji BT, Chan JK, Chu M, Li YJ, Yokota J, Li J, Chen H, Xiang YB, Yu CJ, Kunitoh H, Wu G, Jin L, Lo YL, Shiraishi K, Chen YH, Lin HC, Wu T, Pik Wong M, Wu YL, Yang PC, Zhou B, Shin MH, Fraumeni Jr JF, Zheng W, Lin D, Chanock SJ, Rothman N, Lan Q. Genetic variants associated with longer telomere length are associated with increased lung cancer risk among never-smoking women in Asia: A report from the female lung cancer consortium in Asia. Int J Cancer. 2014;137(2):311-9

Liu AP, Shing MM, Yuen HL, Li CH, Ling SC, Luk CW, Ha SY, Li CK, Kwong DL, Chan GC. Timing of adjuvant radiotherapy and treatment outcome in childhood ependymoma. Pediatr Blood Cancer. 2014; 61(4):606-11.

Li JY, Pow EH, Zheng LW, Ma L, Kwong DL, Cheung LK. Quantitative analysis of titanium-induced artifacts and correlated factors during micro-CT scanning. Clin Oral Implants Res. Clin Oral Implants Res. 2014;25(4):506-10.

Li JY, Pow EH, Zheng LW, Ma L, Kwong DL, Cheung LK. Dose-dependent effect of radiation on titanium implants; a quantative study in rabbits. Clin Oral Implants Res. 2014; 25(2):260-5.

Lee VHF , Chan WWL, Lee EYP, Choy TS, Ho PPY, Leung DKC, Lam KO, Kwong DLW, Leung TW, Khong PL. Prognostic significance of standardized uptake value of lymph nodes on survival for stage III non-small-cell lung cancer treated with definitive concurrent chemoradiotherapy. Am J Clin Oncol. 2014;Aug;39(4):355-62

Lee AWM, Sze H, Lam KO, Chen X. A Tale Of Two Cities In China: Hong Kong And Shenzhen. Int J Radiat Oncol Biol Phys. 2014;89(4):704-708

Lee AWM, Ng WT, Chan YH, Sze H, Chan C, Lam TH. The Battle Against Nasopharyngeal Cancer. Radiother Oncol. 2012;104(3):272-278

Lee AWM, Ng WT, Chan LLK, Hung WM, Chan CCC, Sze HCK, Chan OSH, Chang ATY, Yeung RM. Evolution of Treatment for Nasopharyngeal Cancer - Success and Setback in the Intensity-Modulated Radiotherapy Era. Radiother Oncol. 2014;110(3):377-384,

Lam KO, Law BTT, Law SYK, Kwong DLW. Intraperitoneal chemotherapyfor gastric cancer with peritoneal carcinomatosis: is HIPEC the only answer? Modern Chemotherapy. 2014;3:11-19

Lai V, Li X, Lee VH, Lam KO, Fong DY, Huang B, Chan Q, Khong PL. Nasopharyngeal carcinoma: comparison of diffusion and perfusion characteristics between different tumour stages using intravoxel incoherent motion MR imaging. Eur Radiol. 2014;24:176-183

Lai V, Lee VH, Lam KO, Sze HC, Chan Q, Khong PL. Intravoxel water diffusion heterogeneity MR imaging of nasopharyngeal carcinoma using stretched exponential diffusion model. Eur Radiol. 2015;25(6):1708-13

Kwok H, Wu CW, Palser AL, Kellam P, Sham PC, Kwong DL, Chiang AK. Genomic diversity of epstein-barr virus genomes isolated from primary nasopharyngeal carcinoma biopsy samples. J Virol. 2014;88(18):10662-72.

Kam MKM, Wong FCS; Kwong DLW; Sze HCK, Lee AWM. Current Controversies in Radiotherapy for Nasopharyngeal Carcinoma (NPC). Oral Oncol. 2014;50(10):907-912

EBCTCG (Early Breast Cancer Trialists' Collaborative Group), McGale P, Taylor C, Correa C, Cutter D, Duane F, Ewertz M, Gray R, Mannu G, Peto R, Whelan T, WangY, Wang Z, Darby S. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet. 2014;383(9935):2127-35.

Chung JCK, Lee VHF , Tsang RKY, Chan JYW, Kwong DLW, Lam KO, Sze HCK, Leung TW. Treatment outcomes of post-radiation second head and neck malignancies (PRT-SHNM) managed by a multidisciplinary approach. Head Neck. 2014;37(6):815-822

Cheuk IW, Yip SP, Kwong DL, Wu VW. Association of XRCC1 and XRCC3 gene haplotypes with the development of radiation-induced fibrosis in patients with nasopharyngeal carcinoma. Mol Clin Oncol. 2014 Jul;2(4):553-558.

Cheng SC, Wu VW, Kwong DL, Lui CY, Cheng AC, Kot BC, Ying MT. Sonographic appearance of thyroid glands in patients treated with intensity-modulated radiotherapy or conventional radiotherapy for nasopharyngeal carcinoma. J Clin Ultrasound. 2014;43(4):210-223.

Cheng AL, Li J, Vaid AK, Ma BB, TheC, Ahn JB, Bello M, Charoentum C, Chen LT, de Lima Lopes G Jr, Ho GF, Kong HL, Lam KO, Liu TS, Park YS, Sriuranpong V, Sudoyo AW, Wang JY, Zhang J, Zhang SZ, Ciardiello F, Kohne CH, Shaw M, Kim TW. Adaptation of international guidelines for metastatic colorectal cancer: an Asian consensus. Clin Colorectal Cancer. 2014;13:145-55

Chan WL, Lee VHF, Siu SWK, Leung TW. Inoperable Adenoid Cystic Carcinoma of Trachea: Complete Remission after Multi-modality Treatment. Hong Kong J Radiol. 2014;17:203-7.

Chan WL, Lee VH, Siu WK, Ho PY, Liu RK, Leung TW. Biweekly cetuximab and first-line chemotherapy in chinese patients with k-ras wild-type colorectal cancers. South Asian J Cancer. 2014;3(3):175-8.

Zhang LY, Lee VHF, Wong AM, Kwong DL, Zhu YH, Dong SS, Kong KL, Chen J, Tsao SW, Guan XY, Fu L. MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN. Carcinogenesis. 2013;34(2):454-63.

Ying M, Zheng YP, Kot BC, Cheung JC, Cheng SC, Kwong DL. Three-dimensional elastography for cervical lymph node volume measurements: a study to investigate feasibility, accuracy and reliability. Ultrasound Med Biol. 2013;39(3):396-406.

Wu YL, Lee JS, Thongprasert S, Yu CJ, Zhang L, Ladrera G, Srimuninnimit V, Sriuranpong V, Sandoval-Tan J, Zhu Y, Liao M, Zhou C, Pan H, Lee V, Chen YM, Sun Y, Margono B, Fuerte F, Chang GC, Seetalarom K, Wang J, Cheng A, Syahruddin E, Qian X, Ho J, Krunianda J, Liu HE, Jin K, Truman M, Bara I, Mok T. Intercalated combination of chemotherapy and erlotinib for patients with advanced stage non-small-lung cancer (FASTACT-2): a randomised, double-blind trial. Lancet Oncol. 2013;14:777-786.

Wong CK, Lam CL, Poon JT, Kwong DL. Clinical correlates of health preference and generic health-related quality of life in patients with colorectal neoplasms. PLoS One. 2013; 8(3): e58341.

Wong CK, Lam CL, Mulhern B, Law WL, Poon JT, Kwong DL, Tsang J. Measurement invariance of the Functional Assessment of Cancer Therapy-Colorectal quality-of-life instrument among modes of administration. Qual Life Res. 2013; 22(6): 1415-26.

Wang DD, Zhou W, Yan H, Wong M, Lee V. Personalized prediction of EGFR mutation-induced drug resistance in lung cancer. Sci Rep. 2013;Oct 4;3:2855.

Tian F, Yip SP, Kwong DL, Lin Z, Yang Z, Wu VW. Promotor hypermethylation of tumor suppressor genes in serum as potential biomarker for the diagnosis of nasopharyngeal carcinoma. Cancer Epidemiol. 2013; 37(5):708-13.

Ng SC, Lee VH, Law MW, Liu RK, Ma VW, Tso WK, Leung TW. Patient dosimetry for 90Y selective internal radiation treatment based on 90Y PET imaging. J Appl Clin Med Phys. 2013;14(5):4371.

Luk YS, Shum JSF, Sze HCK, Chan LLK, Ng WT, Lee AWM. Predictive Factors and Radiological Features of Radiation-Induced Cranial Nerve Palsy in Patients with Nasopharyngeal Carcinoma following Radical Radiotherapy. Oral Oncol. 2013; 49(1):49-54.

Lo MC, Yip TC, Ngan KC, Cheng WW, Law CK, Chan PS, Chan KC, Wong CK, Wong RN, Lo KW, Ng WT, Lee WM, Tsao SW, Kwong LW, Lung ML, Mak NK. Role of MIF/CXCL8/CXCR2 signaling in the growth of nasopharyngeal carcinoma tumor spheres. Cancer Lett. 2013;335(1):81-92.

Lee VW, Schwander B, Lee VH. Effectiveness and cost-effectiveness of erlotinib versus gefitinib in first-line treatment of epidermal growth factor receptor-activating mutation-positive non-small-cell lung cancer patients in Hong Kong. Hong Kong Med J. 2013;20(3):178-86

Lee VHF, Kwong DLW. Palliative Chemotherapy and Targeted Therapy for Recurrent and Metastatic Nasopharyngeal Carcinoma: Reminiscences and the Future. Hong Kong J Radiol. 2013;16:252-260.

Lee VH, Tin VP, Choy TS, Lam KO, Choi CW, Chung LP, Tsang JW, Ho PP, Leung DK, Ma ES, Liu J, Shek TW, Kwong DL, Leung TW, Wong MP. Association of Exon 19 and 21 EGFR Mutation Patterns with Treatment Outcome after First-Line Tyrosine Kinase Inhibitor in Metastatic Non-Small-Cell Lung Cancer. J Thorac Oncol. 2013;8:1148-1155.

Lee AWM, Sze H, Ng WT. Is Selective Neck Irradiation Safe for Node-Negative Nasopharyngeal Carcinoma? Int J Radiat Oncol Biol Phys. 2013;85(4):902-903

Lau HY, Leung CM, Chan YH, Lee AWM, Kwong DLW, Lung ML, Lam TH. Secular Trends of Salted Fish Consumption and Nasopharyngeal Carcinoma: A Multi-Jurisdiction Ecological Study in 8 Regions from 3 Continents. BMC Cancer. 2013;13:298

Lam KO. From complexity to simplicity: best level of evidence for metastatic colorectal cancer. Hong Kong J Radiol. 2013;16(4)Suppl:S9-16.

Lam KO. Evolution of neoadjuvant chemoirradiation in rectal cancer. Hong Kong J Radiol. 2012; 15(Suppl):S33-9

Lam KO, Lee VH, Liu RK, Leung TW, Kwong DL. Bevacizumab-containing regimens after cetuximab failure in Kras wild-type metastatic colorectal carcinoma. Oncol Lett. 2013;5(2):637-640.

Lai V, Li X, Lee VH, Lam KO, Chan Q, Khong PL. Intravoxel incoherent motion MR imaging: comparison of diffusion and perfusion characteristics between nasopharyngeal carcinoma and post-chemoradiation fibrosis. Eur Radiol. 2013;23(10):2793-2801.

Huang B, Wong CS, Whitcher B, Kwong DL, Lai V, Chan Q, Khong PL. Dynamic contrast-enhanced magnetic resonance imaging for characterising nasopharyngeal carcinoma: comparison of semiquantitative and quantitative parameters and correlation with tumour stage. Eur Radiol. 2013;23(6):1495-502.

Grégoire V, Ang K, Budach W, Grau C, Hamoir M, Langendijk JA, Lee A, Le QT, Maingon P, Nutting CK, O’Sullivan B, Porceddum SV, Lengele B. Delineation of the Neck Node Levels for Head and Neck Tumors: A 2013 Update. DAHANCA, EORTC, HKNPCSF, NCIC, CTG, NCRI, RTOG, TROG Consensus Guidelines. Radiother Oncol. 2014; 110(1):172-181

Fang WJ, Lam KO, Ng SC, Choi CW, Kwong DL, Zheng SS, Lee VH. Manual contouring based volumetric evaluation for colorectal cancer with liver limited metastases: a comparison with RECIST. Asian Pac J Cancer Prev. 2013;14:4151-5

Fang W, Lam K, Ng S, Choi C, Kwong D, Zeng S, Lee V. Manual contouring based volumetric evaluation for colorectal cancer with liver limited metastases: a comparison with RECIST. Asian Pac J Cancer Prev. 2013;14(7):4151-5.

D’cruz A, Lin T, Anand AK, Atmakusuma D, Calaguas MJ, Chitapanarux I, Cho BC, Goh BC, Guo Y, Hsieh WS, Hu C, Kwong D, Lin JC, Lou PJ, Lu T, Prabhash K, Sriuranpong V, Tang P, Vu VV, Wahid I, Ang KK, Chan AT. Consensus recommendations for management of head and neck cancer in Asian countries: A review of international guidelines. Oral Oncol. 2013;49(9):872-7.

Cheng SC, Ying MT, Kwong DL, Wu VW. Sonographic appearance of submandibular glands in patients treated with external beam radiotherapy for nasopharyngeal carcinoma. J Clin Ultrasound. 2013; 41(8):472-8.

Chen L, Li Y, Lin CH, Chan TH, Chow RK, Song Y, Liu M, Yuan YF, Fu L, Kong KL, Qi L, Li Y, Zhang N, Tong AH, Kwong DL, Man K, Lo CM, Lok S, Tenen DG, Guan XY. Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma. Nat Med. 2013;19(2):209-16.

Chan OSH, Yeung RMW, Lee AWM. Maintenance Therapy in Advanced Non-Small Cell Lung Cancer: A Prime-Time for Change? Chin Med J. 2013; 126(12):2390-2398.

Chan MK, Kwong DL, Tong A, Tam E, Ng SC. Evaluation of dose prediction error and optimization convergence error in four-dimensional inverse planning of robotic stereotactic lung radiotherapy. J Appl Clin Med Phys. 2013; 14(4):4270.

Chan MK, Kwong DL, Tam E, Tong A, Ng SC. Quantifying variability of intrafractional target motion in stereotactic body radiotherapy for lung cancers. J Appl Clin Med Phys. 2013; 14(5):140-52.

Chan MK, Kwong DL, Ng SC, Tong AS, Tam EK. Experimental evaluations of the accuracy of 3D and 4D planning in robotic tracking stereotactic body radiotherapy for lung cancers. Med Phys. 2013; 40(4): 041712.

Chan MK, Kwong DL, Law GM, Tam E, Tong A, Lee V, Ng SC. Dosimetric evaluation of four-dimensional dose distributions of CyberKnife and volumetric-modulated arc radiotherapy in stereotactic body lung radiotherapy. J Appl Clin Med Phys. 2013 Jul 8;14(4):4229.

Chan KC, Ting CM, Chan PS, Lo MC, Lo KW, Curry JE, Smyth T, Lee AWM, Ng WT, Tsao GSW, Wong RNS, Lung ML, Mak NK. A Novel HSP90 Inhibitor AT13387 Induces Senescence in EBV-Positive Nasopharyngeal Carcinoma Cells and Suppresses Tumor Formation. Molecular Cancer. 2013;12(1):128

Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative Group. Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial. Lancet. 2013;381(9869):805-16.

Yau TK, Shum T, Lee AWM, Yeung MW, Ng WT, Chan L. A Phase II Study of Pemetrexed Combined with Cisplatin in Patients with Recurrent or Metastatic Nasopharyngeal Carcinoma. Oral Oncol, . 2012;48(5):441-444

Wong VC, Chen H, Ko JM, Chan KW, Chan YP, Law S, Chua D, Kwong DL, Lung HL, Srivastava G, Tang JC, Tsao SW, Zabarovsky ER, Stanbridge EJ, Lung ML. Tumor suppressor dual-specificity phosphatase 6 (DUSP6) impairs cell invasion and epithelial-mesenchymal transition (EMT)-associated phenotype. Int J Cancer. 2012;130(1):83-95.

Wong CS, Gong N, Chu YC, Anthony MP, Chan Q, Lee HF, Chu KM, Khong PL. Correlation of measurements from diffusion weighted MR imaging and FDG PET/CT in GIST patients: ADC versus SUV. Eur J Radiol. 2012;81(9):2122-2126.

Wong CK, Lam CL, Rowen D, McGhee SM, Ma KP, Law WL, Poon JT, Chan P, Kwong DL, Tsang J. Mapping the Functional Assessment of Cancer Therapy-General or -Colorectal to SF-6D in Chinese Patients with Colorectal Neoplasm. Value Health. 2012;15(3):495-503.

Wong CK, Lam CL, Poon JT, McGhee SM, Law WL, Kwong DL, Tsang J, Chan P. Direct medical costs of care for Chinese patients with colorectal neoplasia: a health care service provider perspective. J Eval Clin Pract. 2012; 18(6): 1203-10.

Wong CK, Lam CL, Law WL, Poon JT, Kwong DL, Tsang J, Wan YF. Condition-specific measure was more responsive than generic measure in colorectal cancer: all but social domains. J Clin Epidemiol. 2013; 66(5): 557-65.

Wong CK, Lam CL, Law WL, Poon JT, Chan P, Kwong DL, Tsang J. Validity and reliability study on traditional Chinese FACT-C in Chinese patients with colorectal neoplasm. J Eval Clin Pract. 2012; 18(6): 1186-95.

Wong AM, Kong KL, Tsang JW, Kwong DL, Guan XY. Profiling of Epstein-Barr virus-encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs. Cancer. 2012; 118(3): 698-710.

Tsang RK, Kwong DL, Ho AC, To VS, Ho WK, Wei WI. Long-term hearing results and otological complications of nasopharyngeal carcinoma patients: comparison between treatment with conventional two-dimensional radiotherapy and intensity-modulated radiotherapy. ORL J Otorhinolaryngol Relat Spec. 2012;74(4):228-233.

Ting CM, Wong CKC, Wong RNS, Lo KW, Lee AWM, Tsao GSW, Lung ML, Mak NK. Role of STAT3/5 and BCL-2/Xl in 2-Methoxyestradiol-Induced Endoreduplication of Nasopharyngeal Carcinoma Cells. Molecular Carcinogenesis. 2012;51(12):963-972

Sze HCK, Ng WT, Chan OSH, Shum TCY, Chan LLK, Lee AWM. Radical Radiotherapy For Nasopharyngeal Carcinoma In Elderly Patients: The Importance Of Co-Morbidity Assessment. Oral Oncol. 2012;48(2):162-167

Sze HCK, Lee MCH, Hung WM, Yau TK, Lee AWM. Rapidarc Radiotherapy Planning for Prostate Cancer: Single-Arc and Double-Arc Techniques vs. Intensity-Modulated Radiotherapy. Med Dosimetry. 2012; 37(1):87-91

Smith C, Tsang J, Beagley L, Chua D, Lee V, Li V, Moss DJ, Coman W, Chan KH, Nicholls J, Kwong D, Khanna R. Effective treatment of metastatic forms of Epstein-barr virus-associated nasopharyngeal carcinoma with a novel adenovirus-based adoptive immunotherapy. Cancer Res. 2012;72(5):1116-1125.

Pow EH, Kwong DL, Sham JS, Lee VH, Ng SC. Can intensity-modulated radiotherapy preserve oral health-related quality of life of nasopharyngeal carcinoma patients? Int J Radiat Oncol Biol Phys. 2012;83(2):e213-221.

Lee VHF, Ng SCY, Leung TW, Au GKH, Kwong DLW. Dosimetric predictors for radiation-induced acute nausea and vomiting in IMRT for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2012;84(1):176-182.

Lee VH, Ng SC, Choi CW, Luk MY, Leung TW, Au GKH, Kwong DLW. Comparative analysis of dosimetric parameters of three different radiation techniques for patients with Graves’ ophthalmopathy treated with retro-orbital irradiation. Radiat Oncol. 2012;7(1):199

Lee AWM, Ng WT, Chan OSH, Sze H. If Concurrent- Adjuvant Chemoradiotherapy is Beneficial for Locoregionally Advanced Nasopharyngeal Carcinoma, would Changing the Sequence to Induction-Concurrent Achieve Better Outcome? Radiat Oncol. 2012;1(2):107-115

Lee AWM, Ng WT, Chan LK, Chan OSH, Hung WM, Chan CC, Cheng PTC, Sze H, Lam TS, Yau TK. The Strength/Weakness of the AJCC/UICC Staging System (7th Edition) for Nasopharyngeal Cancer and Suggestions for Future Improvement. Oral Oncol. 2012;48(10):1007-1013

Lee AWM, Lin JC, Ng WT. Current Management of Nasopharyngeal Cancer. Seminar in Radiat Oncol. 2012;22(3):233-244

Lee AWM, Fee WE Jr, Ng WT, Chan LK. Nasopharyngeal Carcinoma: Salvage of Local Recurrence. Oral Oncol. 2012;48(9):768-774.

Law ALY, Ng WT, Lee MCH, Chan ATS, Fung KH, Li F, Lao WC, Lee AWM. Treatment of Primary Liver Cancer Using Highly-Conformal Radiotherapy with KV-Image Guidance and Respiratory Control. Radiother Oncol. 2012;102(1):56-61

Lan Q, Hsiung CA, Matsuo K, Hong YC, Seow A, Wang Z, Hosgood HD 3rd, Chen K, Wang JC, Chatterjee N, Hu W, Wong MP, Zheng W, Caporaso N, Park JY, Chen CJ, Kim YH, Kim YT, Landi MT, Shen H, Lawrence C, Burdett L, Yeager M, Yuenger J, Jacobs KB, Chang IS, Mitsudomi T, Kim HN, Chang GC, Bassig BA, Tucker M, Wei F, Yin Z, Wu C, An SJ, Qian B, Lee VH, Lu D, Liu J, Jeon HS, Hsiao CF, Sung JS, Kim JH, Gao YT, Tsai YH, Jung YJ, Guo H, Hu Z, Hutchinson A, Wang WC, Klein R, Chung CC, Oh IJ, Chen KY, Berndt SI, He X, Wu W, Chang J, Zhang XC, Huang MS, Zheng H, Wang J, Zhao X, Li Y, Choi JE, Su WC, Park KH, Sung SW, Shu XO, Chen YM, Liu L, Kang CH, Hu L, Chen CH, Pao W, Kim YC, Yang TY, Xu J, Guan P, Tan W, Su J, Wang CL, Li H, Sihoe AD, Zhao Z, Chen Y, Choi YY, Hung JY, Kim JS, Yoon HI, Cai Q, Lin CC, Park IK, Xu P, Dong J, Kim C, He Q, Perng RP, Kohno T, Kweon SS, Chen CY, Vermeulen R, Wu J, Lim WY, Chen KC, Chow WH, Ji BT, Chan JK, Chu M, Li YJ, Yokota J, Li J, Chen H, Xiang YB, Yu CJ, Kunitoh H, Wu G, Jin L, Lo YL, Shiraishi K, Chen YH, Lin HC, Wu T, Wu YL, Yang PC, Zhou B, Shin MH, Fraumeni JF Jr, Lin D, Chanock SJ, Rothman N. Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia. Nat Genet. 2012;44(12):1330-1335.

Lam KO, Lee VH. Metastatic colorectal cancer: optimizing treatment with anti-EGFR monoclonal antibody. J Cancer Therapy. 2012;3:902-911.

Kwong DL. The effect of chemotherapy and radiotherapy on fertility. Hong Kong J Radiol. 2012; 15(3): 136-42.

Kwok H, Tong AH, Lin CH, Lok S, Farrell PJ, Kwong DL, Chiang AK. Genomic sequencing and comparative analysis of epstein-barr virus genome isolated from primary nasopharyngeal carcinoma biopsy. PLoS One. 2012;7(5):e36939.

Kong KL, Kwong DL, Chan TH, Law SY, Chen L, Li Y, Qin YR, Guan XY. MicroRNA-375 inhibits tumor growth and metastasis in oesophageal squamous cell carcinoma through repressing insulin-like growth factor 1 receptor. Gut. 2012; 61(1): 33-42.

Huang Z, Cheng Y, Chiu PM, Cheung FMF, Nicholls JM, Kwong DLW, Lee AWM, Zabarovsky ER, Stanbridge EJ, Lung HL, Lung ML. Tumor Suppressor Alpha B-Crystallin (CRYAB) Associates with the Cadherin/Catenin Adherens Junction and Impairs NPC Progression-Associated Properties. Oncogene. 2012;31(32):3709-3720.

Huang B, Khong PL, Kwong DL, Hung B, Wong CS, Wong CY. Dynamic PET-CT studies for characterizing nasopharyngeal carcinoma metabolism: comparison of analytical methods. Nucl Med Commun. 2012; 33(2): 191-7.

Huang B, Chan T, Kwong DL, Chan WK, Khong PL. Nasopharyngeal carcinoma: investigation of intratumoral heterogeneity with FDG PET/CT. AJR Am J Roentgenol. 2012;199(1):169-74.

Cheung F, Chan O, Ng WT, Chan L. Lee A, Pang SW. The Prognostic Value of Histological Typing in Nasopharyngeal Carcinoma. Oral Oncol. 2012;48(5):429-433.

Cheng HC, Wu VW, Ngan RK, Tang KW, Chan CC, Wong KH, Au SK, Kwong DL. A prospective study on volumetric and dosimetric changes during intensity-modulated radiotherapy for nasopharyngeal carcinoma patients. Radiother Oncol. 2012; 104(3): 317-23.

Chen J, Kwong DL, Zhu CL, Chen LL, Dong SS, Zhang LY, Tian J, Qi CB, Cao TT, Wong AM, Kong KL, Li Y, Liu M, Fu L, Guan XY. RBMS3 at 3p24 inhibits nasopharyngeal carcinoma development via inhibiting cell proliferation, angiogenesis, and inducing apoptosis. PLoS One. 2012;7(9):e44636.

Chen J, Fu L, Zhang LY, Kwong DL, Yan L, Guan XY. Tumor suppressor genes on frequently deleted chromosome 3p in nasopharyngeal carcinoma. Chin J Cancer. 2012;31(5):215-22.

Chen H, Ko JMY, Wong VCL, Hyytiainen M, Keski-Oja J, Chua D, Nicholls JM, Cheung FMF, Lee AWM, Kwong DLW, Chiu PM, Zabarovsky ER, Tsao SW, Tao Q, Kan R, Chan SHK, Stanbridge EJ, Lung ML. LTBP-2 Confers Pleiotropic Suppression and Promotes Dormancy in a Growth Factor Permissive Microenvironment in Nasopharyngeal Carcinoma. Cancer Lett. 2012; 325(1):89-98.

Chan OSH, Yeung RMW, Hung AWM, Lee MCH, Chang ATY, Chan CCC, Lee AWM. Stereotactic Ablative Radiotherapy for Medically Inoperable Early Stage Lung Cancer: Early Outcomes. HK Med J. 2012; 18(5):412-418

Chan MK, Kwong DL, Ng SC, Tong AS, Tam EK. Accuracy and sensitivity of four-dimensional dose calculation to systematic motion variability in stereotatic body radiotherapy (SBRT) for lung cancer. J Appl Clin Med Phys. 2012;13(6):3992.

Chan MK, Kwong DL, Ng SC, Tam EK, Tong AS. Investigation of four-dimensional (4D) Monte Carlo dose calculation in real-time tumor tracking stereotatic body radiotherapy for lung cancers. Med Phys. 2012;39(9):5479-87.

Wu VW, Ying MT, Kwong DL. Evaluation of radiation-induced changes to parotid glands following conventional radiotherapy in patients with nasopharyngeal carcinoma. Br J Radiol. 2011; 84(1005): 843-9.

Wei WI, Kwong DL. Recurrent nasopharyngeal carcinoma: surgical salvage vs. additional chemoradiation. Curr Opin Otolaryngol Head Neck Surg. 2011;9(2): 82-6,

Tse VC, Ng WT, Lee VHF, Lee AWM, Chua DTT, Chau J, McGhee SH. Cost-analysis of XELOX and FOLFOX4 for treatment of colorectal cancer to assist decision-making on reimbursement. BMC Cancer. 2011;11:288.

Tong DK, Law S, Kwong DL, Wei WI, Ng RW, Wong KH. Current management of cervical esophageal cancer. World J Surg. 2011; 35(3): 600-7.

Qin YR, Tang H, Xie F, Liu H, Zhu Y, Ai J, Chen L, Li Y, Kwong DL, Fu L, Guan XY. Characterization of tumor-suppressive function of SOX6 in human esophageal squamous cell carcinoma. Clin Cancer Res. 2011;17(1):46-55.

Pow EH, Law MY, Tsang PC, Perera RA, Kwong DL. Salivary Epstein-Barr virus DNA level in patients with nasopharyngeal carcinoma following radiotherapy. Oral Oncol. 2011; 47(9): 879-82.

Ng WT, Lee MCH, Hung WM, Choi CW, Lee KC, Chan OSH, Lee AWM. Clinical Outcomes and Patterns of Failure after Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma. Int J Radiat Oncol Biol Phys. 2011;79(2):420-428

Lee AWM, Tung SY, Ngan RKC, Chappell R, Chua DTT, Lu TX, Siu L, Tan T, Chan LK, Ng WT, Leung TW, Fu YT, Au GKH, Zhao C, O'Sullivan B, Tan EH, Lau WH. Factors Contributing to the Efficacy of Concurrent-Adjuvant Chemotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma: Combined Analyses of NPC-9901 And NPC-9902 Trials. Eu J Cancer. 2011; 47(5):656-666

Lee AWM, Tung SY, Chan ATC, Chappell R, Fu YT, Lu TX, Tan T, Chua DTT, O'Sullivan B, Tung R, Ng WT, Leung TW, Leung SF, Yau S, Zhao C, Tan EH, Au GKH, Siu L, Fung KK, Lau WH. A Randomized Trial on Addition of Concurrent-Adjuvant Chemotherapy and/or Accelerated Fractionation for Locally-Advanced Nasopharyngeal Carcinoma. Radiother Oncol. 2011;98(1):15-22,

Ho ACW, Lee VHF, To VSH, Kwong DLW, Wei WI. Natural course and tumor doubling time of nasopharyngeal carcinoma. A study of 15 patients. Oral Oncol. 2011;47(8):742-746.

Fu L, Zhang C, Zhang LY, Dong SS, Lu LH, Chen J, Dai Y, Li Y, Kong KL, Kwong DL, Guan XY. Wnt2 secreted by tumor fibroblasts promotes tumor progression in oesophageal cancer by activation of the Wnt/{beta}-catenin signaling pathway. Gut. 2011;60(12):1635-43.

Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomized trials. Lancet. 2011; 378(9793): 771-84.

Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient dat for 10, 801 women in 17 randomized trials. Lancet. 2011; 378(9804): 1707-16.

Chung Y, Law S, Kwong DL, Luk JM. Serum soluble E-cadherin is a potential prognostic marker in esophageal squamous cell carcinoma. Dis Esophagus. 2011;24(1): 49-55.

Choi CW, Lee MCH, Ng WT, Law LY, Yau TK, Lee AWM. An Analysis of the Efficacy of Serial Screening for Familial Nasopharyngeal Carcinoma Based on Markov Chain Models. Familial Cancer. 2011; 10(1):133-139

Cheung AK, Ko JM, Lung HL, Chan KW, Stanbridge EJ, Zabarovsky E, Tokino T, Kashima L, Suzuki T, Kwong DL, Chua D, Tsao SW, Lung ML. Cysteine-rich intestinal protein 2 (CRIP2) acts as a repressor of NF-kappaB-mediated proangiogenic cytokine transcription to suppress tumorigenesis and angiogenesis. Proc Natl Acad Sci USA. 2011;108(20): 8390-5.

Cheng SC, Ying MT, Kwong DL, Wu VW. Sonographic appearance of parotid glands in patients treated with intensity-modulated radiotherapy or conventional radiotherapy for nasopharyngeal carcinoma. Ultrasound Med Biol. 2011;37(2): 220-30.

Cheng SC, Wu VW, Kwong DL, Ying MT. Assessment of post-radiotherapy salivary glands. Br J Radiol. 2011; 84(1001): 393-402.

Cheng HC, Wu VW, Liu ES, Kwong DL. Evaluation of radiation dose and image quality for the Varian cone beam computed tomography system. Int J Radiat Oncol Biol Phys. 2011; 80(1): 291-300.

Chang ATY, Ng WT, Law ALY, Ku KM, Lee MCH, Lee AWM. Adjuvant Chemoradiation for Resected Gastric Cancer: A 10-Year Experience. Gastric Cancer. 2011;14(1):63-71.

Chan YW, Lee VH, Chow VL, To VS, Wei WI. Extracapsular lymph node spread in recurrence nasopharyngeal carcinoma. Laryngoscope. 2011;121(12):2576-2580.

Chan WK, Kwong DL, Yeung DW, Huang B, Khong PL. Prognostic impact of standardized uptake value of F-18 FDG PET/CT in nasopharyngeal carcinoma. Clin Nucl Med. 2011; 36(11): 1007-11.

Chan SH, Cheung FMF, Ng WT, Choi CW; Cheung KN, Yiu KH, Lee AWM. Can the Analysis of ERCC1 Expression Contribute to Individualized Therapy in Nasopharyngeal Carcinoma? Int J Radiat Oncol Biol Phys. 2011; 79(5):1414-1420

Chan RW, Kang SS, Yen HL, Li AC, Tang LL, Yu WC, Yuen KM, Chan IW, Wong DD, Lai WW, Kwong DL, Sihoe AD, Poon LL, Guan Y, Nicholls JM, Peiris JS, Chan MC. Tissue tropism of swine influenza viruses and reassortants in ex vivo cultures of the human respiratory tract and conjunctiva. J Virol. 2011; 85(22) 11581-7.

Chan OSH, Lee MCH, Hung AWM, Chang ATY, Yeung RMW, Lee AWM. The Superiority of Hybrid-Volumetric Arc Therapy (VMAT) Technique over Double Arcs VMAT and 3D-Conformal Technique in the Treatment of Locally Advanced Non-Small Cell Lung Cancer - A Planning Study. Radiother Oncol. 2011; 101(2):298-302

Wei WI, Kwong DL. Current management strategy of nasopharyngeal carcinoma. Clin Exp Otorhinolaryngol. 2010;3(1): 1-12

Tong DK, Law S, Kwong DL, Chan KW, Lam AK, Wong KH. Histological regression of squamous esophageal carcinoma assessed by percentage of residual viable cells after neoadjuvant chemoradiation is an important prognostic factor. Ann Surg Oncol. 2010;17(8): 2184-92

Ng WT, Choi CW, Lee MCH, Law LY, Yau TK, Lee AWM. Outcomes of Nasopharyngeal Carcinoma Screening for High Risk Family Members in Hong Kong. Familial Cancer. 2010;9(2):221-228

Ng DCK, Wong SKH, Ng WT, Lee AWM, Li MKW. Impact of Adjuvant Chemoradiation for Adenocarcinoma of Stomach after Curative Gastrectomy in Chinese: A 7-Year Audit. Surg Practice. 2010; 14(3):85-91

Lee VHF. Shifting the paradigm for maintenance therapy for non-small cell lung cancer. Hong Kong J Radiol. 2010;13(Suppl):S16-21.

Lee AWM, Tung SY, Chua DTT, Ngan RKC, Chappell R, Tung R, Siu L, Ng WT, Sze WK, Au GKH, Law SCK, O'Sullivan B, Yau TK, Leung TW, Au JSK, Sze WM, Choi CW, Fung KK, Lau JT, Lau WH. Randomized Trial of Radiotherapy Plus Concurrent-Adjuvant Chemotherapy vs Radiotherapy Alone for Regionally Advanced Nasopharyngeal Carcinoma. J NCI. 2010;102(15):1188-1198

Kong KL, Kwong DL, Fu L, Chan TH, Chen L, Liu H, Li Y, Zhu YH, Bi J, Qin YR, Law SY, Guan XY. Characterization of a candidate tumor suppressor gene uroplakin 1A in esophageal squamous cell carcinoma. Cancer Res. 2010; 70(21): 8832-41.

Kan MW, Leung LH, Kwong DL, Wong W, Lam N. Peripheral doses from noncoplanar IMRT for pediatric radiation therapy. Med Dosim. 2010;35(4): 255-63.

Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr. 2010;(41): 162-77, 2010.

Chan WK, Mak HK, Huang B, Yueng DW, Kwong DL, Khong PL. Nasopharyngeal carcinoma: relationship between 18F-FDG PET-CT maximum standardized uptake value, metabolic tumor volume and total lesion glycolysis and TNM classification. Nucl Med Commun. 2010; 31(3): 206-10

Chan MC, Chan RW, Yu WC, Ho CC, Yuen KM, Fong JH, Tang LL, Lai WW, Lo AC, Chui WH, Sihoe AD, Kwong DL, Wong DS, Tsao GS, Poon LL, Guan Y, Nicholls JM, Peiris JS. Tropism and innate host responses of the 2009 pandemic H1N1 influenza virus in ex vivo and in vitro cultures of human conjunctiva and respiratory tract. Am J Pathol. 2010;176(4): 1828-40.